<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1477" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1477/" /><meta name="ncbi_pagename" content="Hypochondroplasia - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Hypochondroplasia - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Hypochondroplasia" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2013/09/26" /><meta name="citation_author" content="Michael B Bober" /><meta name="citation_author" content="Gary A Bellus" /><meta name="citation_author" content="Sarah M Nikkel" /><meta name="citation_author" content="George E Tiller" /><meta name="citation_pmid" content="20301650" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1477/" /><meta name="citation_keywords" content="Fibroblast growth factor receptor 3" /><meta name="citation_keywords" content="FGFR3" /><meta name="citation_keywords" content="Hypochondroplasia" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Hypochondroplasia" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Michael B Bober" /><meta name="DC.Contributor" content="Gary A Bellus" /><meta name="DC.Contributor" content="Sarah M Nikkel" /><meta name="DC.Contributor" content="George E Tiller" /><meta name="DC.Date" content="2013/09/26" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1477/" /><meta name="description" content="Hypochondroplasia is a skeletal dysplasia characterized by short stature; stocky build; disproportionately short arms and legs; broad, short hands and feet; mild joint laxity; and macrocephaly. Radiologic features include shortening of long bones with mild metaphyseal flare; narrowing of the inferior lumbar interpedicular distances; short, broad femoral neck; and squared, shortened ilia. The skeletal features are very similar to those seen in achondroplasia but tend to be milder. Medical complications common to achondroplasia (e.g., spinal stenosis, tibial bowing, obstructive apnea) occur less frequently in hypochondroplasia but intellectual disability and epilepsy may be more prevalent. Children usually present as toddlers or school-age children with decreased growth velocity leading to short stature and limb disproportion. Other features also become more prominent over time." /><meta name="og:title" content="Hypochondroplasia" /><meta name="og:type" content="book" /><meta name="og:description" content="Hypochondroplasia is a skeletal dysplasia characterized by short stature; stocky build; disproportionately short arms and legs; broad, short hands and feet; mild joint laxity; and macrocephaly. Radiologic features include shortening of long bones with mild metaphyseal flare; narrowing of the inferior lumbar interpedicular distances; short, broad femoral neck; and squared, shortened ilia. The skeletal features are very similar to those seen in achondroplasia but tend to be milder. Medical complications common to achondroplasia (e.g., spinal stenosis, tibial bowing, obstructive apnea) occur less frequently in hypochondroplasia but intellectual disability and epilepsy may be more prevalent. Children usually present as toddlers or school-age children with decreased growth velocity leading to short stature and limb disproportion. Other features also become more prominent over time." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1477/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/hypochondroplasia/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1477/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE89ABD2E04034F1000000000844037F.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1477_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1477_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/hyper-card/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/x-hed/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1477_"><span class="title" itemprop="name">Hypochondroplasia</span></h1><p class="contrib-group"><span itemprop="author">Michael B Bober</span>, MD, PhD, <span itemprop="author">Gary A Bellus</span>, MD, PhD, <span itemprop="author">Sarah M Nikkel</span>, MD, and <span itemprop="author">George E Tiller</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1477_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1477_ai__"><div class="contrib half_rhythm"><span itemprop="author">Michael B Bober</span>, MD, PhD<div class="affiliation small">Alfred I duPont Hospital for Children<br />Wilmington, Delaware<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.sruomen@rebob.leahcim" class="oemail">gro.sruomen@rebob.leahcim</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Gary A Bellus</span>, MD, PhD<div class="affiliation small">Department of Pediatrics<br />University of Colorado Denver<br />Aurora, Colorado<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.odarolocsnerdlihc@sulleb.yrag" class="oemail">gro.odarolocsnerdlihc@sulleb.yrag</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Sarah M Nikkel</span>, MD<div class="affiliation small">Children&#x02019;s Hospital of Eastern Ontario<br />Ottawa, Ontario<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ac.no.oehc@lekkins" class="oemail">ac.no.oehc@lekkins</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">George E Tiller</span>, MD, PhD<div class="affiliation small">Southern California Permanente<br />Medical Group<br />Los Angeles, California<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.pk@rellit.e.egroeg" class="oemail">gro.pk@rellit.e.egroeg</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">July 15, 1999</span>; Last Update: <span itemprop="dateModified">September 26, 2013</span>.</p><p><em>Estimated reading time: 29 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="hypochondroplasia.Summary" itemprop="description"><h2 id="_hypochondroplasia_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Hypochondroplasia is a skeletal dysplasia characterized by short stature; stocky build; disproportionately short arms and legs; broad, short hands and feet; mild joint laxity; and macrocephaly. Radiologic features include shortening of long bones with mild metaphyseal flare; narrowing of the inferior lumbar interpedicular distances; short, broad femoral neck; and squared, shortened ilia. The skeletal features are very similar to those seen in achondroplasia but tend to be milder. Medical complications common to achondroplasia (e.g., spinal stenosis, tibial bowing, obstructive apnea) occur less frequently in hypochondroplasia but intellectual disability and epilepsy may be more prevalent. Children usually present as toddlers or school-age children with decreased growth velocity leading to short stature and limb disproportion. Other features also become more prominent over time.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>Hypochondroplasia is diagnosed by the recognition of characteristic clinical and radiologic findings that remain controversial. The diagnosis is difficult to make in children under age three years, as skeletal disproportion tends to be mild and many of the radiographic features are subtle during infancy. DNA-based testing is possible and about 70% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>FGFR3</i>. However, there is evidence that <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> heterogeneity exists, implying that pathogenic variants in other as-yet unidentified genes may result in similar, if not identical, phenotypes.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Management of short stature in hypochondroplasia is influenced by parental expectations and concerns; one approach is to address these concerns rather than trying to treat the child. Laminectomy relieves symptoms of spinal stenosis; about 70% of individuals experience relief of symptoms following decompression without laminectomy. Developmental milestones are followed closely during early childhood so that cognitive impairments are addressed with special educational programs. Epilepsy is treated in the standard fashion.</p><p><i>Surveillance</i>: Height, weight, and head circumference should be monitored using achondroplasia-standardized growth curves. The following should be performed at routine well-child visits: neurologic examination for signs of spinal cord compression, history for evidence of sleep apnea, physical evaluation for emerging leg bowing, and monitoring for social adjustment. MRI or CT examination of the foramen magnum is indicated if there is evidence of severe hypotonia, spinal cord compression, or central sleep apnea.</p><p><i>Pregnancy management</i>: Vaginal deliveries are possible, although for each pregnancy, pelvic outlet capacity should be assessed in relation to fetal head size; epidural or spinal anesthetic can be used, but a consultation with an anesthesiologist prior to delivery is recommended to assess the spinal anatomy; spinal stenosis may be aggravated during pregnancy.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>Hypochondroplasia is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. The majority of new cases result from spontaneous pathogenic variants and the unaffected parents of a child with hypochondroplasia have an extremely low risk of having another <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child. An individual with hypochondroplasia who has a partner of average stature is at a 50% risk of having a child with hypochondroplasia. If an affected individual's partner also has hypochondroplasia (or another dominant form of skeletal dysplasia), <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> becomes more complicated because of (1) the risk for inheriting two dominantly inherited skeletal dysplasias, (2) the high incidence of genetic heterogeneity, and (3) the lack of medical literature addressing these circumstances. Prenatal <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> is available if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) in the parent(s) with hypochondroplasia have been identified; however, requests for prenatal testing for conditions such as <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> hypochondroplasia are not common.</p></div></div><div id="hypochondroplasia.Diagnosis"><h2 id="_hypochondroplasia_Diagnosis_">Diagnosis</h2><div id="hypochondroplasia.Clinical_Diagnosis"><h3>Clinical Diagnosis</h3><p>The clinical and radiologic diagnostic criteria for hypochondroplasia remain controversial for several reasons, including the following:</p><ul><li class="half_rhythm"><div>No single radiologic or clinical feature is unique to hypochondroplasia.</div></li><li class="half_rhythm"><div>The expression of many of the established diagnostic features in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals is variable.</div></li><li class="half_rhythm"><div>Locus heterogeneity has been established.</div></li></ul><p>Genetic heterogeneity and lack of agreement on a definitive set of diagnostic criteria have made it difficult to compare data from the many studies reported in the literature [<a class="bk_pop" href="#hypochondroplasia.REF.ravenna.1913.157">Ravenna 1913</a>, <a class="bk_pop" href="#hypochondroplasia.REF.kozlowski.1965.379">Kozlowski &#x00026; Bartkowiak 1965</a>, <a class="bk_pop" href="#hypochondroplasia.REF.beals.1969.728">Beals 1969</a>, <a class="bk_pop" href="#hypochondroplasia.REF.dorst.1969.260">Dorst 1969</a>, <a class="bk_pop" href="#hypochondroplasia.REF.walker.1971.95">Walker et al 1971</a>, <a class="bk_pop" href="#hypochondroplasia.REF.kozlowski.1973.238">Kozlowski 1973</a>, <a class="bk_pop" href="#hypochondroplasia.REF.frydman.1974.223">Frydman et al 1974</a>, <a class="bk_pop" href="#hypochondroplasia.REF.newman.1975.95">Newman &#x00026; Dunbar 1975</a>, <a class="bk_pop" href="#hypochondroplasia.REF.specht.1975">Specht &#x00026; Daentl 1975</a>, <a class="bk_pop" href="#hypochondroplasia.REF.scott.1976.18">Scott 1976</a>, <a class="bk_pop" href="#hypochondroplasia.REF.glasgow.1978.868">Glasgow et al 1978</a>, <a class="bk_pop" href="#hypochondroplasia.REF.hall.1979.95">Hall &#x00026; Spranger 1979</a>, <a class="bk_pop" href="#hypochondroplasia.REF.heselson.1979.79">Heselson et al 1979</a>, <a class="bk_pop" href="#hypochondroplasia.REF.oberklaid.1979.140">Oberklaid et al 1979</a>, <a class="bk_pop" href="#hypochondroplasia.REF.wynnedavies.1981.508">Wynne-Davies et al 1981</a>, <a class="bk_pop" href="#hypochondroplasia.REF.maroteaux.1988.105">Maroteaux &#x00026; Falzon 1988</a>, <a class="bk_pop" href="#hypochondroplasia.REF.song.2012.2456">Song et al 2012</a>]. Nevertheless, it is clear that a complete radiographic survey including skull, pelvis, AP and lateral spine, legs, arms, and hands is absolutely necessary to make a clinical diagnosis of hypochondroplasia.</p><p><b>Physical features.</b> The diagnosis of hypochondroplasia should be considered in individuals who have the following:</p><ul><li class="half_rhythm"><div>Short stature (adult height 128-165 cm; 2-3 SD below the mean in children)</div></li><li class="half_rhythm"><div>Stocky build</div></li><li class="half_rhythm"><div>Shortening of the proximal (rhizomelia) or middle (mesomelia) segments of the extremities</div></li><li class="half_rhythm"><div>Limitation of elbow extension</div></li><li class="half_rhythm"><div>Broad, short hands and feet (brachydactyly)</div></li><li class="half_rhythm"><div>Generalized, mild joint laxity</div></li><li class="half_rhythm"><div>Large head (macrocephaly) with relatively normal facies</div></li></ul><p>Less common but significant clinical features:</p><ul><li class="half_rhythm"><div>Scoliosis</div></li><li class="half_rhythm"><div>Bow legs (genu varum) (usually mild)</div></li><li class="half_rhythm"><div>Lumbar lordosis with protruding abdomen</div></li><li class="half_rhythm"><div>Mild to moderate intellectual disability</div></li><li class="half_rhythm"><div>Learning disabilities</div></li><li class="half_rhythm"><div>Adult-onset osteoarthritis</div></li><li class="half_rhythm"><div>Acanthosis nigricans</div></li><li class="half_rhythm"><div>Temporal lobe epilepsy</div></li></ul><p><b>Radiologic features.</b> The most common radiologic features of hypochondroplasia:</p><ul><li class="half_rhythm"><div>Shortening of long bones with mild metaphyseal flare (especially femora and tibiae)</div></li><li class="half_rhythm"><div>Narrowing of or failure to widen in the inferior lumbar interpedicular distances</div></li><li class="half_rhythm"><div>Mild to moderate brachydactyly</div></li><li class="half_rhythm"><div>Short, broad femoral neck</div></li><li class="half_rhythm"><div>Squared, shortened ilia</div></li></ul><p>Less common but significant radiologic features:</p><ul><li class="half_rhythm"><div>Elongation of the distal fibula</div></li><li class="half_rhythm"><div>Shortening (anterior-posterior) of the lumbar pedicles</div></li><li class="half_rhythm"><div>Dorsal concavity of the lumbar vertebral bodies</div></li><li class="half_rhythm"><div>Shortening of the distal ulna</div></li><li class="half_rhythm"><div>Long ulnar styloid (seen only in adults)</div></li><li class="half_rhythm"><div>Prominence of muscle insertions on long bones</div></li><li class="half_rhythm"><div>Shallow "chevron" deformity of distal femur metaphysis</div></li><li class="half_rhythm"><div>Low articulation of sacrum on pelvis with a horizontal orientation</div></li><li class="half_rhythm"><div>Flattened acetabular roof</div></li></ul><p>The clinical and radiologic features above have all been described in hypochondroplasia, but a consensus opinion of which or how many of these features must be present to confirm a clinical diagnosis does not currently exist. The presence of the above listed radiologic criteria for hypochondroplasia varies significantly among <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. Many of these features are not present in affected infants but develop later in life. The mild end of the hypochondroplasia phenotypic spectrum may overlap with "normal" individuals of short stature, making it difficult to establish a definitive clinical diagnosis in these individuals.</p></div><div id="hypochondroplasia.Molecular_Genetic_Test"><h3>Molecular Genetic Testing</h3><p><b>Gene.</b>
<i>FGFR3</i> is the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in which pathogenic variants are known to cause hypochondroplasia; pathogenic variants throughout the gene have been described [<a class="bk_pop" href="#hypochondroplasia.REF.heuertz.2006.1240">Heuertz et al 2006</a>]. Genetic heterogeneity is suspected, as only approximately 70% of those individuals with a clinical and radiographic diagnosis of hypochondroplasia have pathogenic variants in <i>FGFR3</i>; to date, a true second <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> has not been found.</p><p><b>Evidence for <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> heterogeneity</b></p><ul><li class="half_rhythm"><div>Using diagnostic criteria based solely on the radiographic finding of decreased interpediculate distance between L1 and L5, <a class="bk_pop" href="#hypochondroplasia.REF.mullis.1991.265">Mullis et al [1991]</a> studied 20 children with hypochondroplasia. Two RFLPs identified within introns of <i>IGF1</i> (12q23) showed a positive LOD score of 3.31 in some families with hypochondroplasia. To date, no further refinement of the genetic <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> on 12q23 has been reported and no pathogenic variants have been reported in <i>IGF1</i>.</div></li><li class="half_rhythm"><div>It is likely that, in the future, further combined molecular and clinical studies will lead to the discovery of other genetically distinct subtypes of hypochondroplasia.</div></li></ul><div id="hypochondroplasia.T.molecular_genetic_te" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Hypochondroplasia</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1477/table/hypochondroplasia.T.molecular_genetic_te/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__hypochondroplasia.T.molecular_genetic_te_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_hypochondroplasia.T.molecular_genetic_te_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_hypochondroplasia.T.molecular_genetic_te_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_hypochondroplasia.T.molecular_genetic_te_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pathogenic Variants Detected&#x000a0;<sup>2</sup></th><th id="hd_h_hypochondroplasia.T.molecular_genetic_te_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variant Detection Frequency by Method&#x000a0;<sup>3</sup></th></tr></thead><tbody><tr><td headers="hd_h_hypochondroplasia.T.molecular_genetic_te_1_1_1_1" rowspan="4" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>FGFR3</i></td><td headers="hd_h_hypochondroplasia.T.molecular_genetic_te_1_1_1_2" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">Targeted analysis for pathogenic variants&#x000a0;<sup>4</sup></td><td headers="hd_h_hypochondroplasia.T.molecular_genetic_te_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="figpopup" href="/books/NBK1477/table/hypochondroplasia.T.fgfr3_pathogenic_var/?report=objectonly" target="object" rid-figpopup="fighypochondroplasiaTfgfr3pathogenicvar" rid-ob="figobhypochondroplasiaTfgfr3pathogenicvar">c.1620C&#x0003e;A</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_hypochondroplasia.T.molecular_genetic_te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">70%&#x000a0;<sup>6</sup></td></tr><tr><td headers="hd_h_hypochondroplasia.T.molecular_genetic_te_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><a class="figpopup" href="/books/NBK1477/table/hypochondroplasia.T.fgfr3_pathogenic_var/?report=objectonly" target="object" rid-figpopup="fighypochondroplasiaTfgfr3pathogenicvar" rid-ob="figobhypochondroplasiaTfgfr3pathogenicvar">c.1620C&#x0003e;G</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_hypochondroplasia.T.molecular_genetic_te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">30%&#x000a0;<sup>5</sup></td></tr><tr><td headers="hd_h_hypochondroplasia.T.molecular_genetic_te_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>7</sup></td><td headers="hd_h_hypochondroplasia.T.molecular_genetic_te_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence variants (including <a class="figpopup" href="/books/NBK1477/table/hypochondroplasia.T.fgfr3_pathogenic_var/?report=objectonly" target="object" rid-figpopup="fighypochondroplasiaTfgfr3pathogenicvar" rid-ob="figobhypochondroplasiaTfgfr3pathogenicvar">c.1620C&#x0003e;A</a> and <a class="figpopup" href="/books/NBK1477/table/hypochondroplasia.T.fgfr3_pathogenic_var/?report=objectonly" target="object" rid-figpopup="fighypochondroplasiaTfgfr3pathogenicvar" rid-ob="figobhypochondroplasiaTfgfr3pathogenicvar">c.1620C&#x0003e;G</a></td><td headers="hd_h_hypochondroplasia.T.molecular_genetic_te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>8</sup></td></tr><tr><td headers="hd_h_hypochondroplasia.T.molecular_genetic_te_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Deletion/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> analysis&#x000a0;<sup>9</sup></td><td headers="hd_h_hypochondroplasia.T.molecular_genetic_te_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Exon or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a></td><td headers="hd_h_hypochondroplasia.T.molecular_genetic_te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown, none reported&#x000a0;<sup>10</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="hypochondroplasia.TF.1.1"><p class="no_margin">See <a href="/books/NBK1477/#hypochondroplasia.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="hypochondroplasia.TF.1.2"><p class="no_margin">See <a href="#hypochondroplasia.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants.</p></div></dd><dt>3. </dt><dd><div id="hypochondroplasia.TF.1.3"><p class="no_margin">The ability of the test method used to detect a variant that is present in the indicated <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a></p></div></dd><dt>4. </dt><dd><div id="hypochondroplasia.TF.1.4"><p class="no_margin">Variant panels may vary by laboratory.</p></div></dd><dt>5. </dt><dd><div id="hypochondroplasia.TF.1.5"><p class="no_margin">The two most common pathogenic variants, detection frequency based on testing of 188 individuals with hypochondroplasia. See also <a href="#hypochondroplasia.Testing_Strategy">Testing Strategy</a>.</p></div></dd><dt>6. </dt><dd><div id="hypochondroplasia.TF.1.6"><p class="no_margin">In studies in which a diagnosis was established by physical and radiologic criteria, 70% (180/258) of probands with hypochondroplasia were found to be <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for one <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> resulting in c.1620C&#x0003e;A [<a class="bk_pop" href="#hypochondroplasia.REF.prinos.1995.2097">Prinos et al 1995</a>, <a class="bk_pop" href="#hypochondroplasia.REF.bellus.1996.182">Bellus et al 1996</a>, <a class="bk_pop" href="#hypochondroplasia.REF.rousseau.1996.749">Rousseau et al 1996</a>, <a class="bk_pop" href="#hypochondroplasia.REF.fofanova.1998.791">Fofanova et al 1998</a>, <a class="bk_pop" href="#hypochondroplasia.REF.prinster.1998.109">Prinster et al 1998</a>, <a class="bk_pop" href="#hypochondroplasia.REF.ramaswami.1998.99">Ramaswami et al 1998</a>, <a class="bk_pop" href="#hypochondroplasia.REF.heuertz.2006.1240">Heuertz et al 2006</a>].</p></div></dd><dt>7. </dt><dd><div id="hypochondroplasia.TF.1.7"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>8. </dt><dd><div id="hypochondroplasia.TF.1.8"><p class="no_margin"><a class="bk_pop" href="#hypochondroplasia.REF.heuertz.2006.1240">Heuertz et al [2006]</a> reported 54 <i>FGFR3</i> pathogenic variants detected by sequencing all coding regions in 74 probands with hypochondroplasia (47 [87%] were <a class="figpopup" href="/books/NBK1477/table/hypochondroplasia.T.fgfr3_pathogenic_var/?report=objectonly" target="object" rid-figpopup="fighypochondroplasiaTfgfr3pathogenicvar" rid-ob="figobhypochondroplasiaTfgfr3pathogenicvar">c.1620C&#x0003e;A</a>), whereas <a class="bk_pop" href="#hypochondroplasia.REF.song.2012.2456">Song et al [2012]</a>, using broader diagnostic criteria for hypochondroplasia to diagnose 58 individuals, found 19 <i>FGFR3</i> pathogenic variants (10 [58%] were <a class="figpopup" href="/books/NBK1477/table/hypochondroplasia.T.fgfr3_pathogenic_var/?report=objectonly" target="object" rid-figpopup="fighypochondroplasiaTfgfr3pathogenicvar" rid-ob="figobhypochondroplasiaTfgfr3pathogenicvar">c.1620C&#x0003e;A</a>).</p></div></dd><dt>9. </dt><dd><div id="hypochondroplasia.TF.1.9"><p class="no_margin">Testing that identifies deletions/duplications not readily detectable by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of the coding and flanking <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> regions of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> (CMA) that includes this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>/<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> segment.</p></div></dd><dt>10. </dt><dd><div id="hypochondroplasia.TF.1.10"><p class="no_margin">No deletions or duplications involving <i>FGFR3</i> have been reported to cause hypochondroplasia.</p></div></dd></dl></div></div></div></div><div id="hypochondroplasia.Testing_Strategy"><h3>Testing Strategy</h3><p><b>To confirm/establish the diagnosis in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><p><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> One strategy for molecular diagnosis of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> suspected of having hypochondroplasia is <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> (or targeted pathogenic variants) of <i>FGFR3</i>.</p><ul><li class="half_rhythm"><div>Targeted analysis for the two common pathogenic variants should be pursued first.</div></li><li class="half_rhythm"><div>Sequence analysis can be performed when the suspicion of hypochondroplasia based on clinical and radiographic grounds is high and targeted analysis for the two common pathogenic variants is normal. As pathogenic variants have been reported in almost all domains of the protein, analysis should include sequencing of all coding regions. To date, only pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants have been described.</div></li></ul><p><b>Multigene panel.</b> Another strategy for molecular diagnosis of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> suspected of having hypochondroplasia is use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>. For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p></div></div><div id="hypochondroplasia.Clinical_Characteristi"><h2 id="_hypochondroplasia_Clinical_Characteristi_">Clinical Characteristics</h2><div id="hypochondroplasia.Clinical_Description"><h3>Clinical Description</h3><p><b>Growth.</b> The most common presenting feature of children with hypochondroplasia is short stature with disproportionate limbs. Birth weight and length are often within the normal range and the disproportion in limb-to-trunk length is often mild and easily overlooked during infancy. Typically, these children present as toddlers or school-age children to pediatricians or pediatric endocrinologists with decreased growth velocity leading to short stature. Some investigators have reported the absence of a pubertal growth spurt [<a class="bk_pop" href="#hypochondroplasia.REF.appan.1990.796">Appan et al 1990</a>, <a class="bk_pop" href="#hypochondroplasia.REF.bridges.1991.56">Bridges et al 1991</a>]. Overall height is usually two to three standard deviations below the mean during childhood, and adult heights range from 138 to 165 cm (54" to 65") for men and 128 to 151 cm (50" to 59") for women [<a class="bk_pop" href="#hypochondroplasia.REF.maroteaux.1988.105">Maroteaux &#x00026; Falzon 1988</a>, <a class="bk_pop" href="#hypochondroplasia.REF.appan.1990.796">Appan et al 1990</a>].</p><p>With age, limb disproportion usually becomes more prominent in the legs than the arms. Both rhizomelic [<a class="bk_pop" href="#hypochondroplasia.REF.frydman.1974.223">Frydman et al 1974</a>, <a class="bk_pop" href="#hypochondroplasia.REF.specht.1975">Specht &#x00026; Daentl 1975</a>, <a class="bk_pop" href="#hypochondroplasia.REF.maroteaux.1988.105">Maroteaux &#x00026; Falzon 1988</a>] and mesomelic [<a class="bk_pop" href="#hypochondroplasia.REF.beals.1969.728">Beals 1969</a>, <a class="bk_pop" href="#hypochondroplasia.REF.walker.1971.95">Walker et al 1971</a>] shortening have been reported, although others have reported the predominance of neither [<a class="bk_pop" href="#hypochondroplasia.REF.hall.1979.95">Hall &#x00026; Spranger 1979</a>]. The hands are relatively short but do not exhibit the "trident" appearance that is typical in achondroplasia. Facial features are usually normal and the classic facial features of achondroplasia (e.g., midfaceretrusion, frontal bossing) are not generally seen. Head size may be large without significant disproportion.</p><p><b>Orthopedics.</b> When children begin to walk, exaggerated lumbar lordosis and mild genu varum (bow legs) are often noted. The genu varum is usually transient and rarely requires surgical intervention. Young children and adults often have a thick, muscular appearance and may be described as "stocky." Joint pain, back pain, and other symptoms of osteoarthritis may occur later in life. Multiple suture craniosynostosis has been reported in one case [<a class="bk_pop" href="#hypochondroplasia.REF.angle.1998.417">Angle et al 1998</a>].</p><p><b>Cognitive development.</b> The incidence of intellectual disability is thought to be higher in hypochondroplasia than in achondroplasia or the general population. This observation has been controversial and several studies have reported conflicting results [<a class="bk_pop" href="#hypochondroplasia.REF.beals.1969.728">Beals 1969</a>, <a class="bk_pop" href="#hypochondroplasia.REF.walker.1971.95">Walker et al 1971</a>, <a class="bk_pop" href="#hypochondroplasia.REF.frydman.1974.223">Frydman et al 1974</a>, <a class="bk_pop" href="#hypochondroplasia.REF.specht.1975">Specht &#x00026; Daentl 1975</a>, <a class="bk_pop" href="#hypochondroplasia.REF.hall.1979.95">Hall &#x00026; Spranger 1979</a>, <a class="bk_pop" href="#hypochondroplasia.REF.wynnedavies.1991.644">Wynne-Davies &#x00026; Patton 1991</a>]. It is unclear whether these discrepancies result from sampling bias, genetic heterogeneity, or both; more studies with rigorous diagnostic criteria are required to resolve this issue. Preliminary studies [Bellus &#x00026; Francomano, unpublished results] suggest that individuals with the <i>FGFR3</i> p.Asn540Lys substitution may have an increased incidence of mild-to-moderate intellectual disability or learning disabilities. Eight of 13 Finnish individuals with the <i>FGFR3</i> p.Asn540Lys substitution had neurocognitive difficulties [<a class="bk_pop" href="#hypochondroplasia.REF.linnankivi.2012.3119">Linnankivi et al 2012</a>] (see <b>Neurology</b>).</p><p><b>Endocrinology.</b> Acanthosis nigricans is observed occasionally in children and adults with hypochondroplasia [<a class="bk_pop" href="#hypochondroplasia.REF.leroy.2007.3144">Leroy et al 2007</a>, <a class="bk_pop" href="#hypochondroplasia.REF.castrofeij_o.2008.243">Castro-Feij&#x000f3;o et al 2008</a>, <a class="bk_pop" href="#hypochondroplasia.REF.alatzoglou.2009.3959">Alatzoglou et al 2009</a>, <a class="bk_pop" href="#hypochondroplasia.REF.berk.2010.664">Berk et al 2010</a>, <a class="bk_pop" href="#hypochondroplasia.REF.blomberg.2010.297">Blomberg et al 2010</a>] and appears to be more prevalent in individuals with specific <i>FGFR3</i> pathogenic variants (i.e., p.Lys650Gln and p.Lys650Thr). The severity of acanthosis nigricans in individuals reported with these pathogenic variants is much milder than that observed in SADDAN syndrome (<i>FGFR3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> p.Lys650Met). While increased insulin resistance has been reported in one individual with acanthosis nigricans and hypochondroplasia due to a p.Lys650Gln pathogenic variant [<a class="bk_pop" href="#hypochondroplasia.REF.blomberg.2010.297">Blomberg et al 2010</a>], no evidence of insulin resistance was found in an individual with acanthosis nigricans and hypochondroplasia due to a p.Asn540Lys pathogenic variant [<a class="bk_pop" href="#hypochondroplasia.REF.alatzoglou.2009.3959">Alatzoglou et al 2009</a>]. Insulin resistance is also not found in SADDAN syndrome [<a class="bk_pop" href="#hypochondroplasia.REF.bellus.1999.53">Bellus et al 1999</a>].</p><p><b>Neurology.</b> Symptoms of spinal stenosis are seen in some adults with hypochondroplasia, but occur much less frequently and tend to be milder than those seen in achondroplasia [<a class="bk_pop" href="#hypochondroplasia.REF.wynnedavies.1981.508">Wynne-Davies et al 1981</a>]. Unlike achondroplasia, motor milestones are usually not significantly delayed and symptoms resulting from spinal cord compression (e.g., apnea, neuropathy) are less common [<a class="bk_pop" href="#hypochondroplasia.REF.wynnedavies.1981.508">Wynne-Davies et al 1981</a>].</p><p><a class="bk_pop" href="#hypochondroplasia.REF.hulse.2012">Hulse et al [2012]</a> described a male with hypochondroplasia (p.Asn540Lys) who developed seizures in the neonatal period. EEGs revealed abnormalities in the left temporal lobe region, and brain MRI revealed abnormal orientation of the hippocampal heads. Reference was made to four other reported cases of medial temporal lobe epilepsy related to hypochondroplasia.</p><p><a class="bk_pop" href="#hypochondroplasia.REF.linnankivi.2012.3119">Linnankivi et al [2012]</a> assessed neurologic and neuroimaging aspects of 13 Finnish individuals with hypochondroplasia with a confirmed <i>FGFR3</i> p.Asn540Lys substitution. Eight <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals had neurocognitive difficulties, ranging from specific learning disorder (2/13) to mild intellectual disability (5/13) or global developmental delay (1/13). Six of 13 affected individuals had a history of epilepsy. Of eight individuals who underwent head MRI, all had temporal lobe dysgenesis, six had peritrigonal white matter reduction, and four had abnormally shaped lateral ventricles.</p></div><div id="hypochondroplasia.GenotypePhenotype_Corr"><h3>Genotype-Phenotype Correlations</h3><p>Other than <a class="figpopup" href="/books/NBK1477/table/hypochondroplasia.T.fgfr3_pathogenic_var/?report=objectonly" target="object" rid-figpopup="fighypochondroplasiaTfgfr3pathogenicvar" rid-ob="figobhypochondroplasiaTfgfr3pathogenicvar">p.Asn540Lys</a>, most pathogenic variants have not been reported in high enough frequency to make any generalizations about specific <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>/<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> manifestations.</p><ul><li class="half_rhythm"><div>As one would expect, no difference exists in <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> between the <i>FGFR3</i>
<a class="figpopup" href="/books/NBK1477/table/hypochondroplasia.T.fgfr3_pathogenic_var/?report=objectonly" target="object" rid-figpopup="fighypochondroplasiaTfgfr3pathogenicvar" rid-ob="figobhypochondroplasiaTfgfr3pathogenicvar">c.1620C&#x0003e;A</a> and <a class="figpopup" href="/books/NBK1477/table/hypochondroplasia.T.fgfr3_pathogenic_var/?report=objectonly" target="object" rid-figpopup="fighypochondroplasiaTfgfr3pathogenicvar" rid-ob="figobhypochondroplasiaTfgfr3pathogenicvar">c.1620C&#x0003e;G</a> pathogenic variants, as they result in identical mutated proteins, p.Asn540Lys. In general, it appears that the phenotypes of individuals diagnosed with hypochondroplasia who have <i>FGFR3</i> pathogenic variants c.1620C&#x0003e;A or c.1620C&#x0003e;G have more severe manifestations than those with hypochrondroplasia who do not have these pathogenic variants [<a class="bk_pop" href="#hypochondroplasia.REF.rousseau.1996.749">Rousseau et al 1996</a>, <a class="bk_pop" href="#hypochondroplasia.REF.prinster.1998.109">Prinster et al 1998</a>, <a class="bk_pop" href="#hypochondroplasia.REF.ramaswami.1998.99">Ramaswami et al 1998</a>]. More recently, both <a class="bk_pop" href="#hypochondroplasia.REF.heuertz.2006.1240">Heuertz et al [2006]</a> and <a class="bk_pop" href="#hypochondroplasia.REF.song.2012.2456">Song et al [2012]</a> reported that a p.Tyr278Cys (<a class="figpopup" href="/books/NBK1477/table/hypochondroplasia.T.fgfr3_pathogenic_var/?report=objectonly" target="object" rid-figpopup="fighypochondroplasiaTfgfr3pathogenicvar" rid-ob="figobhypochondroplasiaTfgfr3pathogenicvar">c.829A&#x0003e;G</a>) <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> resulted in a phenotype that resembled achondroplasia in the newborn period. There is still no consensus as to which specific clinical features distinguish hypochondroplasia due to <i>FGFR3</i> p.Asn540Lys from hypochondroplasia caused by other <i>FGFR3</i> pathogenic variants or from non-<i>FGFR3</i>-related hypochondroplasia.</div></li><li class="half_rhythm"><div><a class="bk_pop" href="#hypochondroplasia.REF.fano.2005.782">Fano et al [2005]</a> reported that <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with a head circumference greater than 1.86 standard deviations had a greater likelihood of possessing the p.Asn540Lys <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>Individuals with p.Lys650Gln or p.Lys650Thr have a higher likelihood of developing acanthosis nigricans (see <a href="#hypochondroplasia.Clinical_Description">Clinical Description</a>, <b>Endocrinology</b>).</div></li><li class="half_rhythm"><div>Pathogenic variants resulting in <a class="figpopup" href="/books/NBK1477/table/hypochondroplasia.T.fgfr3_pathogenic_var/?report=objectonly" target="object" rid-figpopup="fighypochondroplasiaTfgfr3pathogenicvar" rid-ob="figobhypochondroplasiaTfgfr3pathogenicvar">p.Lys650Asn</a> and <a class="figpopup" href="/books/NBK1477/table/hypochondroplasia.T.fgfr3_pathogenic_var/?report=objectonly" target="object" rid-figpopup="fighypochondroplasiaTfgfr3pathogenicvar" rid-ob="figobhypochondroplasiaTfgfr3pathogenicvar">p.Lys650Gln</a> are associated with a slightly milder skeletal <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> than pathogenic variants resulting in p.Asn540Lys. <a class="bk_pop" href="#hypochondroplasia.REF.bellus.2000.1411">Bellus et al [2000]</a> reported six individuals with p.Lys650Asn or p.Lys650Gly who had a significantly lower average height deficit than 36 individuals with p.Asn540Lys. In addition, the L1:L4 interpediculate distance and fibula/tibia length ratios were closer to normal.</div></li><li class="half_rhythm"><div><a class="bk_pop" href="#hypochondroplasia.REF.mortier.2000.220">Mortier et al [2000]</a> and <a class="bk_pop" href="#hypochondroplasia.REF.thauvinrobinet.2003.81">Thauvin-Robinet et al [2003]</a> reported on families with p.Asn540Lys. The <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in both families was relatively mild, with heights overlapping the lower end of the normal range for age, mild disproportion of the limbs, and macrocephaly.</div></li></ul><p>Somatic <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> has not been reported in hypochondroplasia.</p></div><div id="hypochondroplasia.Penetrance"><h3>Penetrance</h3><p>Because of evidence that the height range in hypochondroplasia may overlap that of the normal population, individuals with hypochondroplasia may not be recognized as having a skeletal dysplasia unless an astute physician recognizes their disproportionate short stature. However, there have been no reports of individuals with an <i>FGFR3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> without demonstrable radiographic changes compatible with hypochondroplasia or one of the other phenotypes known to be associated with pathogenic variants in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> (see <a href="#hypochondroplasia.Genetically_Related_Al">Genetically Related Disorders</a>).</p></div><div id="hypochondroplasia.Anticipation"><h3>Anticipation</h3><p>Genetic <a class="def" href="/books/n/gene/glossary/def-item/anticipation/">anticipation</a> is not known to occur in hypochondroplasia.</p></div><div id="hypochondroplasia.Prevalence"><h3>Prevalence</h3><p>No studies attempting to determine the prevalence of <i>FGFR3</i> and/or non-<i>FGFR3</i> hypochondroplasia have been published. Ascertainment of cases is problematic as it is thought that many <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals present with no symptoms other than short stature and do not seek medical intervention. However, it is generally agreed that hypochondroplasia is a relatively common skeletal dysplasia that may approach the prevalence of achondroplasia (i.e., one in 15,000 - 40,000 live births). In addition, <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (affected individuals with no family history of hypochondroplasia) have been associated with advanced paternal age. Simplex cases of hypochondroplasia caused by the <i>FGFR3</i> p.Asn540Lys <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> are probably not as common as simplex cases of achondroplasia, given the fact that a transition at a CpG dinucleotide is the most common cause of the <a href="/books/n/gene/achondroplasia/">achondroplasia</a>-causing p.Gly380Arg change, while both pathogenic variants leading to <a class="figpopup" href="/books/NBK1477/table/hypochondroplasia.T.fgfr3_pathogenic_var/?report=objectonly" target="object" rid-figpopup="fighypochondroplasiaTfgfr3pathogenicvar" rid-ob="figobhypochondroplasiaTfgfr3pathogenicvar">p.Asn540Lys</a> result from transversions not associated with CpG dinucleotides.</p></div></div><div id="hypochondroplasia.Genetically_Related_Al"><h2 id="_hypochondroplasia_Genetically_Related_Al_">Genetically Related (Allelic) Disorders</h2><p>The other phenotypes associated with pathogenic variants in <i>FGFR3</i>:</p><ul><li class="half_rhythm"><div><a href="/books/n/gene/td/">Thanatophoric dysplasia</a> (TD) is a short-limb dwarfism syndrome that is usually lethal in the perinatal period. TD is divided into type I, characterized by micromelia with bowed femurs and, uncommonly, the presence of cloverleaf skull deformity (kleeblattschaedel) of varying severity; and type II, characterized by micromelia with straight femurs and uniform presence of moderate-to-severe cloverleaf skull deformity. Other features common to type I and type II include: short ribs, narrow thorax, macrocephaly, distinctive facial features, brachydactyly, hypotonia, and redundant skin folds along the limbs. Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> infants die of respiratory insufficiency shortly after birth. Rare long-term survivors have been reported.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/achondroplasia/">Achondroplasia</a>. It should be noted that mild cases of achondroplasia caused by <i>FGFR3</i> p.Gly380Arg substitutions and severe cases of hypochondroplasia caused by <i>FGFR3</i> p.Asn540Lys may have very similar clinical presentations and are thus easily confused. Therefore, it is important to test for both <i>FGFR3</i> pathogenic variants resulting in p.Asn540Lys and both pathogenic variants resulting in p.Gly380Arg (c.1138G&#x0003e;A and c.1138G&#x0003e;C) when molecular testing is requested for hypochondroplasia.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/craniosynostosis/"><i>FGFR</i>-related craniosynostosis</a>. The eight disorders comprising the <i>FGFR</i>-related craniosynostosis spectrum are Pfeiffer syndrome, <a href="/books/n/gene/apert/">Apert syndrome</a>, Crouzon syndrome, Beare-Stevenson syndrome, <i>FGFR2</i>-related <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> coronal synostosis, Jackson-Weiss syndrome, Crouzon syndrome with acanthosis nigricans (AN), and <a href="/books/n/gene/muenke/">Muenke syndrome</a> (isolated coronal synostosis caused by the p.Pro250Arg <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>FGFR3</i>). Muenke syndrome and <i>FGFR2</i>-related isolated coronal synostosis are characterized only by uni- or bicoronal craniosynostosis; the remainder are characterized by bicoronal craniosynostosis or cloverleaf skull, distinctive facial features, and variable hand and foot findings.</div></li><li class="half_rhythm"><div>SADDAN (<i>s</i>evere <i>a</i>chondroplasia with <i>d</i>evelopmental <i>d</i>elay and <i>a</i>canthosis <i>n</i>igricans) is caused by <i>FGFR3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> p.Lys650Met [<a class="bk_pop" href="#hypochondroplasia.REF.bellus.1999.53">Bellus et al 1999</a>, <a class="bk_pop" href="#hypochondroplasia.REF.tavormina.1999.722">Tavormina et al 1999</a>].</div></li></ul></div><div id="hypochondroplasia.Differential_Diagnosis"><h2 id="_hypochondroplasia_Differential_Diagnosis_">Differential Diagnosis</h2><p>Numerous forms of skeletal dysplasia with disproportionate limbs are recognized and are characterized by clinical and radiologic features that distinguish them from hypochondroplasia and achondroplasia. Many of these disorders are quite rare. The diagnosis of hypochondroplasia is seldom made at birth unless a prior family history exists. Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals present with short stature as toddlers or young school-age children. Inappropriate diagnoses of hypochondroplasia are often made because the disorder is considered to be relatively common and the radiologic features are variable and may be subtle. The following conditions may be confused with hypochondroplasia:</p><ul><li class="half_rhythm"><div>Mild <a href="/books/n/gene/achondroplasia/">achondroplasia</a></div></li><li class="half_rhythm"><div>Mild forms of metaphyseal chondrodysplasias</div></li><li class="half_rhythm"><div>Mild forms of mesomelic dwarfism</div></li><li class="half_rhythm"><div>Mild forms of spondyloepiphyseal-metaphyseal dysplasias</div></li><li class="half_rhythm"><div><a href="/books/n/gene/lwd/">Leri-Weill dyschondrosteosis</a></div></li><li class="half_rhythm"><div>Pseudohypoparathyroidism and pseudopseudohypoparathyroidism (see <a href="/books/n/gene/gnas-dis/">Disorders of <i>GNAS</i> Inactivation</a>)</div></li><li class="half_rhythm"><div>Short stature caused by disturbances in the growth hormone axis</div></li><li class="half_rhythm"><div>Constitutive short stature</div></li></ul><p><b>Hypochondroplasia-achondroplasia complex</b> (<i>FGFR3</i> p.[Asn540Lys];[Gly380Arg]) has been reported [<a class="bk_pop" href="#hypochondroplasia.REF.mckusick.1973.11">McKusick et al 1973</a>, <a class="bk_pop" href="#hypochondroplasia.REF.sommer.1987.949">Sommer et al 1987</a>, <a class="bk_pop" href="#hypochondroplasia.REF.bellus.1995.357">Bellus et al 1995</a>, <a class="bk_pop" href="#hypochondroplasia.REF.huggins.1999.396">Huggins et al 1999</a>, <a class="bk_pop" href="#hypochondroplasia.REF.flynn.2003.193">Flynn &#x00026; Pauli 2003</a>, <a class="bk_pop" href="#hypochondroplasia.REF.bober.2012.2336">Bober et al 2012</a>]. The skeletal <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is more severe than typically found in achondroplasia, but unlike <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> achondroplasia, is not uniformly lethal. Life span, however, may be decreased.</p><p><b>Hypochondroplasia-<i>SHOX</i> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>.</b>
<a class="bk_pop" href="#hypochondroplasia.REF.ross.2003.61">Ross et al [2003]</a> described the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in one child with compound heterozygosity for Leri-Weil dyschondrosteosis and hypochondroplasia. This child inherited both a <i>SHOX</i> deletion and the p.Asn540Lys <i>FGFR3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, and had severe short stature with both rhizomelic and mesomelic shortening of the limbs.</p></div><div id="hypochondroplasia.Management"><h2 id="_hypochondroplasia_Management_">Management</h2><div id="hypochondroplasia.Evaluations_Following"><h3>Evaluations Following Initial Diagnosis</h3><p>Evaluation of children with hypochondroplasia usually does not differ significantly from the evaluation of children with normal stature except for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> issues and dealing with parental concerns about short stature. However, because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of <i>FGFR3</i> hypochondroplasia may overlap with that of achondroplasia, recommendations for the management of achondroplasia as outlined by the American Academy of Pediatrics Committee on Genetics [<a class="bk_pop" href="#hypochondroplasia.REF.trotter.2005.771">Trotter et al 2005</a>] should be considered in children with hypochondroplasia who exhibit more severe phenotypic features. These recommendations include but are not limited to the following:</p><ul><li class="half_rhythm"><div>Clinical genetics consultation</div></li><li class="half_rhythm"><div>Measurement of height, weight, and head circumference and plotting on achondroplasia-standardized growth curves</div></li><li class="half_rhythm"><div>Neurologic examination for signs of spinal cord compression, with referral to a pediatric neurologist or neurosurgeon if needed</div></li><li class="half_rhythm"><div>Screening developmental assessment</div></li><li class="half_rhythm"><div>History for evidence of sleep apnea, with formal sleep study if suggestive</div></li><li class="half_rhythm"><div>MRI or CT examination of the foramen magnum if clinical findings of severe hypotonia, spinal cord compression, or central sleep apnea as demonstrated through a sleep study are present</div></li><li class="half_rhythm"><div>Evaluation for thoracic or lumbar gibbus in the presence of truncal weakness</div></li><li class="half_rhythm"><div>Examination for leg bowing, with orthopedic referral if bowing interferes with walking</div></li><li class="half_rhythm"><div>Speech evaluation at diagnosis or by age two years</div></li><li class="half_rhythm"><div>Observation for symptoms suggestive of epilepsy, with referral to a pediatric neurologist when indicated</div></li></ul></div><div id="hypochondroplasia.Treatment_of_Manifesta"><h3>Treatment of Manifestations</h3><p>Management of short stature is influenced by parental expectations and concerns. Final adult height in hypochondroplasia is considerably greater than that achieved in achondroplasia and therefore, functional limitations in society (e.g., operating an elevator, driving a car, using an automatic teller machine) are generally less severe or not an issue. One reasonable approach is to address the parents' expectations and prejudices regarding the height of their child rather than attempting to treat the child.</p><p>Developmental intervention and special educational input are appropriate, as indicated by deficiencies.</p><p>The usual neurosurgical approach to spinal stenosis is laminectomy. <a class="bk_pop" href="#hypochondroplasia.REF.thomeer.2002.292">Thomeer &#x00026; van Dijk [2002]</a> determined that about 70% of symptomatic individuals with <a href="/books/n/gene/achondroplasia/">achondroplasia</a> experienced total relief of symptoms following decompression without laminectomy. The L2-3 level most commonly required decompression.</p><p>Making the family aware of support groups, such as the Little People of America Inc. (LPA), can result in assistance with adaptation of the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual and the family to short stature through peer support, personal example, and social awareness programs. The LPA offers information on employment, education, disability rights, adoption of children of short stature, medical issues, suitable clothing, adaptive devices, and parenting through local meetings, workshops, seminars, and a national newsletter.</p><p>Seizure disorders should be treated in the standard manner.</p></div><div id="hypochondroplasia.Prevention_of_Secondar"><h3>Prevention of Secondary Complications</h3><p>The following are appropriate:</p><ul><li class="half_rhythm"><div>Standard management of frequent middle ear infections</div></li><li class="half_rhythm"><div>Consideration of surgery if neurologic status is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> by spinal cord compression</div></li></ul></div><div id="hypochondroplasia.Surveillance"><h3>Surveillance</h3><p>Height, weight, and head circumference should be monitored using achondroplasia-standardized growth curves.</p><p>Because an increased prevalence of mild-to-moderate intellectual disability and/or learning disabilities in children with hypochondroplasia appears likely, developmental milestones should be followed closely during early childhood and a timely referral to an appropriate professional made if there are any indications of learning difficulties during school-age years.</p><p>Neurologic examination for signs of spinal cord compression should be performed at routine well-child visits, with referral to a pediatric neurologist if needed.</p><p>History for evidence of sleep apnea should be taken at routine visits, with formal sleep study obtained when indicated.</p><p>MRI or CT examination of the foramen magnum is indicated if there is evidence of severe hypotonia, spinal cord compression or central sleep apnea.</p><p>Affected individuals should be evaluated for emerging leg bowing at routine visits, with orthopedic referral if bowing interferes with walking.</p><p>Social adjustment should be monitored.</p></div><div id="hypochondroplasia.Evaluation_of_Relative"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#hypochondroplasia.Related_Genetic_Counse">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p><p><b>Pregnancy Management</b></p><p>There is a paucity of literature regarding pregnancy management in women with skeletal dysplasias. However, a number of women with hypochondroplasia have had unremarkable pregnancies and deliveries.</p><ul><li class="half_rhythm"><div>In comparison to women who have achondroplasia, vaginal deliveries are possible, although for each pregnancy, pelvic outlet capacity should be assessed in relation to fetal head size.</div></li><li class="half_rhythm"><div>Epidural or spinal anesthetic can be utilized, but a consultation with an anesthesiologist prior to delivery is recommended to assess the spinal anatomy.</div></li><li class="half_rhythm"><div>If present, spinal stenosis may be aggravated during pregnancy due to the normal physiologic changes to the shape of the spine that occur as gestation progresses.</div></li></ul></div><div id="hypochondroplasia.Therapies_Under_Invest"><h3>Therapies Under Investigation</h3><p><b>Growth hormone therapy.</b> Trials of growth hormone therapy in hypochondroplasia have shown mixed results. These differences in individual responses published prior to <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> discovery in 1995 [<a class="bk_pop" href="#hypochondroplasia.REF.appan.1990.796">Appan et al 1990</a>, <a class="bk_pop" href="#hypochondroplasia.REF.bridges.1991.56">Bridges et al 1991</a>, <a class="bk_pop" href="#hypochondroplasia.REF.mullis.1991.265">Mullis et al 1991</a>, <a class="bk_pop" href="#hypochondroplasia.REF.bridges.1994.231">Bridges &#x00026; Brook 1994</a>] may have resulted from genetic heterogeneity and indicate a need for stratification of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with regard to genetic etiology (e.g., those with <i>FGFR3</i> pathogenic variants and those without). <a class="bk_pop" href="#hypochondroplasia.REF.meyer.2003.177">Meyer et al [2003]</a> emphasized the importance of considering pubertal development in assessing the response to growth hormone stimulation testing. <a class="bk_pop" href="#hypochondroplasia.REF.tanaka.2003.69">Tanaka et al [2003]</a> reported data suggesting that children with hypochondroplasia may have a greater response to growth hormone therapy than children with achondroplasia.</p><p><a class="bk_pop" href="#hypochondroplasia.REF.pinto.2012.193">Pinto et al [2012]</a> treated 19 children with hypochondroplasia (11/19 with confirmed <i>FGFR3</i> pathogenic variants, mean age 9.0+/-3.0 years) with human recombinant growth hormone over a three-year period. Their mean height increased 1.32+/-1.05 standard deviation score (SDS) compared to a historical cohort of 40 untreated individuals with hypochondroplasia. <a class="bk_pop" href="#hypochondroplasia.REF.rothenbuhler.2012.849">Rothenbuhler et al [2012]</a> treated six children with hypochondroplasia (confirmed <i>FGFR3</i> p.Asn540Lys substitution, mean age 2.6+/-0.7 years) with human recombinant growth hormone over a six-year period. Their mean height SDS increased by 1.9 during the study period, and trunk/leg disproportion was improved. Since data about final adult height in growth hormone-treated individuals with hypochondroplasia are not available, the ultimate success of this approach remains uncertain. Growth hormone therapy should still be considered experimental and controversial in this condition.</p><p><b>Surgical limb lengthening procedures</b> have been used to treat achondroplasia and hypochondroplasia for more than 15 years. Although the complication rate was high initially, outcomes have steadily improved and significant increases in overall height have been reported [<a class="bk_pop" href="#hypochondroplasia.REF.yasui.1997.298">Yasui et al 1997</a>, <a class="bk_pop" href="#hypochondroplasia.REF.lie.2009.280">Lie &#x00026; Chow 2009</a>]. Nevertheless, the procedure is very invasive and entails considerable disability and discomfort over a long period of time. While some advocate performing the procedure during childhood, many pediatricians, geneticists, and ethicists advocate postponement until adolescence, when the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual is able to make an informed decision. Surgical limb lengthening is controversial, but is achieving greater acceptance with fewer complications as larger numbers of operations have been performed.</p><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions.</p></div></div><div id="hypochondroplasia.Genetic_Counseling"><h2 id="_hypochondroplasia_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="hypochondroplasia.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Hypochondroplasia is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="hypochondroplasia.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The majority of individuals with hypochondroplasia have parents of average stature and represent <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> occurrences caused by a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>; however, in some instances, one or both parents have hypochondroplasia.</div></li><li class="half_rhythm"><div>There appears to be a paternal age effect in some <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> occurrences of hypochondroplasia [<a class="bk_pop" href="#hypochondroplasia.REF.walker.1971.95">Walker et al 1971</a>]. It is likely that <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variants occur on the paternally derived <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> during spermatogenesis, as has been shown in achondroplasia [<a class="bk_pop" href="#hypochondroplasia.REF.wilkin.1998.711">Wilkin et al 1998</a>] and Apert syndrome [<a class="bk_pop" href="#hypochondroplasia.REF.moloney.1996.48">Moloney et al 1996</a>].</div></li><li class="half_rhythm"><div>Because the skeletal features of hypochondroplasia are milder than those of achondroplasia and the incidence of disabilities is lower, the reproductive fitness of individuals with hypochondroplasia is most likely greater than that of individuals with achondroplasia. It is likely that the number of families with multiple <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> members is higher for hypochondroplasia than for achondroplasia, and that the percentage of cases of hypochondroplasia attributable to <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variants is less than the 80% figure stated for achondroplasia.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to sibs of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the genetic status of the parents.</div></li><li class="half_rhythm"><div>If one parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, the risk is 50%.</div></li><li class="half_rhythm"><div>If both parents have hypochondroplasia or one has hypochondroplasia and the other has a different <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> skeletal dysplasia, the risk to sibs is more complex (see <b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b>).</div></li><li class="half_rhythm"><div>Germline <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> has not been reported for hypochondroplasia and therefore the risk that the sibs of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual born to parents of normal stature would have hypochondroplasia appears to be extremely low (&#x0003c;0.01%).</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>An individual with hypochondroplasia who has a reproductive partner of average stature is at a 50% risk of having a child with hypochondroplasia.</div></li><li class="half_rhythm"><div>When the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> and the proband's reproductive partner are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> with the same or a different skeletal dysplasia, <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> is more complicated. In general, if both members of a couple have a dominantly inherited skeletal dysplasia, each child has a 25% chance of having normal stature, a 25% chance of having the same skeletal dysplasia as the father, a 25% chance of having the same skeletal dysplasia as the mother, and a 25% chance of inheriting a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> from both parents and being at risk for a potentially poor pregnancy outcome.</div><ul><li class="half_rhythm"><div>Individuals <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> for <i>FGFR3</i> variants p.Asn540Lys and Gly380Arg (the pathogenic variants that cause hypochondroplasia and achondroplasia, respectively) or individuals in whom the hypochondroplasia results from <i>FGFR3</i> p.Asn540Lys have a severe skeletal <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> with the potential for serious disability [<a class="bk_pop" href="#hypochondroplasia.REF.mckusick.1973.11">McKusick et al 1973</a>, <a class="bk_pop" href="#hypochondroplasia.REF.sommer.1987.949">Sommer et al 1987</a>, <a class="bk_pop" href="#hypochondroplasia.REF.huggins.1999.396">Huggins et al 1999</a>].</div></li><li class="half_rhythm"><div>Poor outcomes have been reported for individuals who are compound heterozygotes for achondroplasia and spondyloepiphyseal dysplasia congenita [<a class="bk_pop" href="#hypochondroplasia.REF.young.1992.831">Young et al 1992</a>, <a class="bk_pop" href="#hypochondroplasia.REF.g_nthard.1995.35">G&#x000fc;nthard et al 1995</a>] or achondroplasia and pseudoachondroplasia [<a class="bk_pop" href="#hypochondroplasia.REF.langer.1993.772">Langer et al 1993</a>].</div></li><li class="half_rhythm"><div>Compound heterozygotes for either achondroplasia and dyschondrosteosis or hypochondroplasia and dyschondrosteosis have phenotypes that do not appear to be more severe than that of either parent [<a class="bk_pop" href="#hypochondroplasia.REF.ross.2003.61">Ross et al 2003</a>].</div></li></ul></li><li class="half_rhythm"><div>Genetic counseling of couples both of whom have hypochondroplasia is complicated by (1) genetic heterogeneity and (2) lack of information about the phenotypes and prognosis for offspring who inherit a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> from both parents. No reports address the following phenotypes:</div><ul><li class="half_rhythm"><div>Individuals with hypochondroplasia who are <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for <i>FGFR3</i> pathogenic variants or homozygous for non-<i>FGFR3</i> pathogenic variants</div></li><li class="half_rhythm"><div>Individuals who are compound heterozygotes for an <i>FGFR3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and a non-<i>FGFR3</i> pathogenic variant</div></li></ul></li><li class="half_rhythm"><div>Similarly, the following phenotypes have not been described:</div><ul><li class="half_rhythm"><div>Individuals who are compound heterozygotes for a non-<i>FGFR3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> causing hypochondroplasia and an <i>FGFR3</i> pathogenic variant causing achondroplasia</div></li><li class="half_rhythm"><div>Individuals who are compound heterozygotes for hypochondroplasia (as a result of either an <i>FGFR3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> or a pathogenic variant in a different <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>) and another dominantly inherited skeletal dysplasia (except individuals who are compound heterozygotes for <i>FGFR3</i> pathogenic variants causing hypochondroplasia and achondroplasia. See above: Individuals who are compound heterozygotes for <i>FGFR3</i>).</div></li><li class="half_rhythm"><div>Therefore, it is not possible to provide information about prognosis for all at-risk offspring.</div></li></ul></li></ul><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents. If a parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, his or her family members are at risk.</p></div><div id="hypochondroplasia.Related_Genetic_Counse"><h3>Related Genetic Counseling Issues</h3><p>Genetic counseling for hypochondroplasia presents dilemmas relating to ethical and genetic issues. Hypochondroplasia is considered a mild disorder in which the chief physical disability is generally short stature. Many <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals do not think of themselves as disabled. However, some parents may consider short stature a significant physical, emotional, and/or social disability. Furthermore, a child with hypochondroplasia may have intellectual disability or a learning disability. An additional issue is genetic heterogeneity (i.e., pathogenic variants in more than one <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> causing hypochondroplasia), which may result in an inability to predict <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> or prognosis and/or make diagnosis difficult.</p><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic variant or clinical evidence of the disorder, it is likely that the proband has a <i>de novo</i> pathogenic variant. However, possible non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="hypochondroplasia.Prenatal_Testing_and_P"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p><b>High-risk pregnancy</b></p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Molecular genetic testing.</b> A high-risk pregnancy is one in which one parent has hypochondroplasia and the other parent is of normal stature, has hypochondroplasia, or has another dominantly inherited skeletal dysplasia. Prenatal testing for a high-risk pregnancy is possible. The <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the parent with hypochondroplasia must be identified before prenatal testing can be performed. Similarly, if the other parent has a dominantly inherited skeletal dysplasia, the causative variant must be identified before prenatal testing is possible.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Fetal ultrasound examination.</b> If the causative variant for the other disorder present in the couple is not known or if the variant causing hypochondroplasia cannot be identified, ultrasound examination is the only method of prenatal testing. It is often possible to detect an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> fetus early in the pregnancy if the fetus is at risk of being a compound <a class="def" href="/books/n/gene/glossary/def-item/heterozygote/">heterozygote</a> with another dominantly inherited skeletal dysplasia. However, it is currently difficult to detect <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> hypochondroplasia or other milder phenotypes using ultrasonography. Signs of disproportionate growth may suggest the diagnosis of hypochondroplasia, but a "normal" third trimester ultrasound examination is not sufficient to rule out a diagnosis of hypochondroplasia. The <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> hypochondroplasia has not yet been described; therefore, no statement can be made regarding <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> of homozygous hypochondroplasia by ultrasound examination.</div><div class="half_rhythm">If significant macrocephaly is noted, it is appropriate to consider delivery by cesarean section to reduce the risk of potential CNS complications associated with a vaginal delivery.</div></li></ul><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p><p><b>Low-risk pregnancy.</b> A fetus with a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>FGFR3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> causing hypochondroplasia who exhibits short limbs may be detected by routine ultrasound examination late in pregnancy [<a class="bk_pop" href="#hypochondroplasia.REF.jones.1990.404">Jones et al 1990</a>]. DNA-based diagnosis (i.e., <i>FGFR3</i> p.Asn540Lys and p.Gly380Arg analysis for pathogenic variants) via amniocentesis may be helpful in ruling out lethal forms of skeletal dysplasia and establishing a more favorable prognosis for the fetus.</p><p><b>Preimplantation genetic diagnosis (PGD)</b> may be an option for some families in which the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified.</p></div></div><div id="hypochondroplasia.Resources"><h2 id="_hypochondroplasia_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>My46 Trait Profile</b></div><div><a href="https://www.my46.org/trait-document?trait=Hypochondroplasia&#x00026;parent=Genetic%20Syndromes&#x00026;type=profile" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Hypochondroplasia</a></div></li><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="https://ghr.nlm.nih.gov/condition/hypochondroplasia" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Hypochondroplasia</a></div></li><li class="half_rhythm"><div><b>Child Growth Foundation</b></div><div>21 Malvern Drive</div><div>West Midlands B76 1PZ</div><div>United Kingdom</div><div><b>Phone:</b> 020 8995 0257</div><div><b>Email:</b> nfo@childgrowthfoundation.org</div><div><a href="http://www.childgrowthfoundation.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.childgrowthfoundation.org</a></div></li><li class="half_rhythm"><div><b>Human Growth Foundation (HGF)</b></div><div>997 Glen Cove Avenue</div><div>Suite 5</div><div>Glen Head NY 11545</div><div><b>Phone:</b> 800-451-6434 (toll-free)</div><div><b>Fax:</b> 516-671-4055</div><div><b>Email:</b> hgf1@hgfound.org</div><div><a href="http://www.hgfound.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.hgfound.org</a></div></li><li class="half_rhythm"><div><b>Little People of America, Inc. (LPA)</b></div><div>250 El Camino Real</div><div>Suite 201</div><div>Tustin CA 92780</div><div><b>Phone:</b> 888-572-2001 (toll-free); 714-368-3689</div><div><b>Fax:</b> 714-368-3367</div><div><b>Email:</b> info@lpaonline.org</div><div><a href="http://www.lpaonline.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.lpaonline.org</a></div></li><li class="half_rhythm"><div><b>MAGIC Foundation</b></div><div>4200 Cantera Drive #106</div><div>Warrenville IL 60555</div><div><b>Phone:</b> 800-362-4423 (Toll-free Parent Help Line); 630-836-8200</div><div><b>Fax:</b> 630-836-8181</div><div><b>Email:</b> contactus@magicfoundation.org</div><div><a href="http://www.magicfoundation.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.magicfoundation.org</a></div></li><li class="half_rhythm"><div><b>Medline Plus</b></div><div><a href="http://www.nlm.nih.gov/medlineplus/dwarfism.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Dwarfism</a></div></li><li class="half_rhythm"><div><b>International Skeletal Dysplasia Registry</b></div><div>UCLA</div><div>615 Charles E. Young Drive</div><div>South Room 410</div><div>Los Angeles CA 90095-7358</div><div><b>Phone:</b> 310-825-8998</div><div><b>Fax:</b> 310-206-5266</div><div><b>Email:</b> Salon@mednet.ucla.edu</div><div><a href="https://www.uclahealth.org/ortho/isdr" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">International Skeletal Dysplasia Registry</a></div></li></ul></div><div id="hypochondroplasia.Molecular_Genetics"><h2 id="_hypochondroplasia_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="hypochondroplasia.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Hypochondroplasia: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1477/table/hypochondroplasia.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__hypochondroplasia.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_hypochondroplasia.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_hypochondroplasia.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_hypochondroplasia.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_hypochondroplasia.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_hypochondroplasia.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_hypochondroplasia.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_hypochondroplasia.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/2261" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>FGFR3</i></a></td><td headers="hd_b_hypochondroplasia.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=2261" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">4p16<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_hypochondroplasia.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P22607" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Fibroblast growth factor receptor 3</a></td><td headers="hd_b_hypochondroplasia.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/FGFR3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FGFR3 @ LOVD</a></td><td headers="hd_b_hypochondroplasia.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=FGFR3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FGFR3</a></td><td headers="hd_b_hypochondroplasia.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=FGFR3[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FGFR3</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="hypochondroplasia.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="hypochondroplasia.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Hypochondroplasia (<a href="/omim/134934,146000" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1477/table/hypochondroplasia.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__hypochondroplasia.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/134934" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">134934</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">FIBROBLAST GROWTH FACTOR RECEPTOR 3; FGFR3</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/146000" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">146000</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HYPOCHONDROPLASIA; HCH</td></tr></tbody></table></div></div><p><b>Gene structure.</b> The 4.3-kb <a class="def" href="/books/n/gene/glossary/def-item/cdna/">cDNA</a> has 19 exons and encodes an 806-residue protein (isoform 1). For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1477/#hypochondroplasia.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> A recurrent <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (c.1620C&#x0003e;A, p.Asn540Lys) in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 13 that encodes the ATP-binding segment of the tyrosine kinase <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> was found in eight of 14 individuals with hypochondroplasia and reported first by <a class="bk_pop" href="#hypochondroplasia.REF.bellus.1995.357">Bellus et al [1995]</a>. Subsequently, another pathogenic variant at the same nucleotide resulting in the same amino acid substitution (c.1620C&#x0003e;G, p.Asn540Lys) was reported [<a class="bk_pop" href="#hypochondroplasia.REF.prinos.1995.2097">Prinos et al 1995</a>, <a class="bk_pop" href="#hypochondroplasia.REF.bellus.1996.182">Bellus et al 1996</a>]. These two pathogenic variants account for the majority of more than 200 reported cases of hypochondroplasia [<a class="bk_pop" href="#hypochondroplasia.REF.bellus.1995.357">Bellus et al 1995</a>, <a class="bk_pop" href="#hypochondroplasia.REF.prinos.1995.2097">Prinos et al 1995</a>, <a class="bk_pop" href="#hypochondroplasia.REF.bellus.1996.182">Bellus et al 1996</a>, <a class="bk_pop" href="#hypochondroplasia.REF.bonaventure.1996.33">Bonaventure et al 1996</a>, <a class="bk_pop" href="#hypochondroplasia.REF.fofanova.1998.791">Fofanova et al 1998</a>, <a class="bk_pop" href="#hypochondroplasia.REF.matsui.1998.1052">Matsui et al 1998</a>, <a class="bk_pop" href="#hypochondroplasia.REF.prinster.1998.109">Prinster et al 1998</a>, <a class="bk_pop" href="#hypochondroplasia.REF.ramaswami.1998.99">Ramaswami et al 1998</a>]. Several other <i>FGFR3</i> pathogenic variants have been proposed as the cause of a small number of cases of hypochondroplasia. (For more information, see <a href="/books/NBK1477/#hypochondroplasia.molgen.TA">Table A</a>.)</p><div id="hypochondroplasia.T.fgfr3_pathogenic_var" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p><i>FGFR3</i> Pathogenic Variants That Cause Hypochondroplasia Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1477/table/hypochondroplasia.T.fgfr3_pathogenic_var/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__hypochondroplasia.T.fgfr3_pathogenic_var_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_hypochondroplasia.T.fgfr3_pathogenic_var_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change<br />(Alias&#x000a0;<sup>1</sup>)</th><th id="hd_h_hypochondroplasia.T.fgfr3_pathogenic_var_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_hypochondroplasia.T.fgfr3_pathogenic_var_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_hypochondroplasia.T.fgfr3_pathogenic_var_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.829A&#x0003e;G</td><td headers="hd_h_hypochondroplasia.T.fgfr3_pathogenic_var_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Tyr278Cys</td><td headers="hd_h_hypochondroplasia.T.fgfr3_pathogenic_var_1_1_1_3" rowspan="7" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_000142.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000142<wbr style="display:inline-block"></wbr>​.4</a><br /><a href="/protein/NP_000133.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000133<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_hypochondroplasia.T.fgfr3_pathogenic_var_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1612A&#x0003e;G</td><td headers="hd_h_hypochondroplasia.T.fgfr3_pathogenic_var_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ile538Val</td></tr><tr><td headers="hd_h_hypochondroplasia.T.fgfr3_pathogenic_var_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1619A&#x0003e;C</td><td headers="hd_h_hypochondroplasia.T.fgfr3_pathogenic_var_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asn540Thr</td></tr><tr><td headers="hd_h_hypochondroplasia.T.fgfr3_pathogenic_var_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1620C&#x0003e;A<br />(C1659A)</td><td headers="hd_h_hypochondroplasia.T.fgfr3_pathogenic_var_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asn540Lys</td></tr><tr><td headers="hd_h_hypochondroplasia.T.fgfr3_pathogenic_var_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1620C&#x0003e;G<br />(C1659G)</td><td headers="hd_h_hypochondroplasia.T.fgfr3_pathogenic_var_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asn540Lys</td></tr><tr><td headers="hd_h_hypochondroplasia.T.fgfr3_pathogenic_var_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1950G&#x0003e;T</td><td headers="hd_h_hypochondroplasia.T.fgfr3_pathogenic_var_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Lys650Asn</td></tr><tr><td headers="hd_h_hypochondroplasia.T.fgfr3_pathogenic_var_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1948A&#x0003e;C</td><td headers="hd_h_hypochondroplasia.T.fgfr3_pathogenic_var_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Lys650Gln</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature</p></div></dd><dt>1. </dt><dd><div id="hypochondroplasia.TF.2.1"><p class="no_margin">Variant designation that does not conform to current naming conventions</p></div></dd></dl></div></div></div><p>For more information see <a href="/books/NBK1477/bin/hypochondroplasia-Table3.pdf">Table 3</a> (pdf).</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Fibroblast growth factor receptor 3 is a receptor tyrosine kinase and a member of the fibroblast growth factor receptor family. This family comprises four related genes in mammals (<i>FGFR1</i> - <i>FGFR4</i>) with highly conserved structure. The FGFR genes are all characterized by an extracellular ligand-binding <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> consisting of three immunoglobulin (Ig) subdomains, a transmembrane domain, and a split intracellular tyrosine kinase domain [<a class="bk_pop" href="#hypochondroplasia.REF.johnson.1993.1">Johnson &#x00026; Williams 1993</a>]. A stretch of four to eight acidic amino acids termed the acid box (whose function is not known) is found between the first and second Ig domains. Alternative <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> of FGFR transcripts results in several distinct <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a> that may lack one or more Ig domains, the acid box, or the intracellular tyrosine kinase domain. Some isoforms have regions of alternative sequence within the extracellular Ig domains. Exons eight and nine are alternatively spliced and encode different carboxyl termini of the third Ig domain. Alternative splicing of the FGFR genes is thought to modulate the affinity of the numerous FGFs for the receptor and may control other aspects of receptor-mediated signaling.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The effects of the <i>FGFR3</i> pathogenic variants on FGFR3 function have been shown to result in constitutive activation of the receptor tyrosine kinase [<a class="bk_pop" href="#hypochondroplasia.REF.naski.1996.233">Naski et al 1996</a>, <a class="bk_pop" href="#hypochondroplasia.REF.webster.1996.520">Webster &#x00026; Donoghue 1996</a>, <a class="bk_pop" href="#hypochondroplasia.REF.webster.1996.4081">Webster et al 1996</a>, <a class="bk_pop" href="#hypochondroplasia.REF.thompson.1997.4169">Thompson et al 1997</a>, <a class="bk_pop" href="#hypochondroplasia.REF.tavormina.1999.722">Tavormina et al 1999</a>]. It therefore appears likely that the <i>FGFR3</i> pathogenic variants found in hypochondroplasia may result in constitutive activation of the receptor tyrosine kinase, but to a lesser degree than these other pathogenic variants. Such appears to be the case in hypochondroplasia resulting from p.Lys650Asn [G Bellus, D Donoghue, M Webster, C Francomano, unpublished results]. The premise that <i>FGFR3</i> <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a> pathogenic variants cause skeletal dysplasia is supported by the observation that targeted disruption of <i>FGFR3</i> in mice results in enhanced growth of long bones and vertebrae, suggesting that <i>FGFR3</i> normally functions as a negative regulator of bone growth [<a class="bk_pop" href="#hypochondroplasia.REF.colvin.1996.390">Colvin et al 1996</a>, <a class="bk_pop" href="#hypochondroplasia.REF.deng.1996.911">Deng et al 1996</a>].</p></div><div id="hypochondroplasia.References"><h2 id="_hypochondroplasia_References_">References</h2><div id="hypochondroplasia.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.alatzoglou.2009.3959">Alatzoglou KS, Hindmarsh PC, Brain C, Torpiano J, Dattani MT. Acanthosis nigricans and insulin sensitivity in patients with achondroplasia and hypochodroplasia due to FGFR3 mutations. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2009;<span class="ref-vol">94</span>:3959–63.</span> [<a href="/pubmed/19622626" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19622626</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.angle.1998.417">Angle B, Hersh JH, Christensen KM. Molecularly proven hypochondroplasia with cloverleaf skull deformity: a novel association. <span><span class="ref-journal">Clin Genet. </span>1998;<span class="ref-vol">54</span>:417–20.</span> [<a href="/pubmed/9842995" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9842995</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.appan.1990.796">Appan S, Laurent S, Chapman M, Hindmarsh PC, Brook CG. Growth and growth hormone therapy in hypochondroplasia. <span><span class="ref-journal">Acta Paediatr Scand. </span>1990;<span class="ref-vol">79</span>:796–803.</span> [<a href="/pubmed/2239275" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2239275</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.beals.1969.728">Beals RK. Hypochondroplasia. A report of five kindreds. <span><span class="ref-journal">J Bone Joint Surg [Am] </span>1969;<span class="ref-vol">51</span>:728–36.</span> [<a href="/pubmed/5783850" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 5783850</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.bellus.1999.53">Bellus GA, Bamshad MJ, Przylepa KA, Dorst J, Lee RR, Hurko O, Jabs EW, Curry CJ, Wilcox WR, Lachman RS, Rimoin DL, Francomano CA. Severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN): phenotypic analysis of a new skeletal dysplasia caused by a Lys650Met mutation in fibroblast growth factor receptor 3. <span><span class="ref-journal">Am J Med Genet. </span>1999;<span class="ref-vol">85</span>:53–65.</span> [<a href="/pubmed/10377013" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10377013</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.bellus.1995.357">Bellus GA, McIntosh I, Smith EA, Aylsworth AS, Kaitila I, Horton WA, Greenhaw GA, Hecht JT, Francomano CA. A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia. <span><span class="ref-journal">Nat Genet. </span>1995;<span class="ref-vol">10</span>:357–9.</span> [<a href="/pubmed/7670477" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7670477</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.bellus.1996.182">Bellus GA, McIntosh I, Szabo J, Aylsworth A, Kaitila I, Francomano CA. Hypochondroplasia: molecular analysis of the fibroblast growth factor receptor 3 gene. <span><span class="ref-journal">Ann N Y Acad Sci. </span>1996;<span class="ref-vol">785</span>:182–7.</span> [<a href="/pubmed/8702125" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8702125</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.bellus.2000.1411">Bellus GA, Spector EB, Speiser PW, Weaver CA, Garber AT, Bryke CR, Israel J, Rosengren SS, Webster MK, Donoghue DJ, Francomano CA. Distinct missense mutations of the FGFR3 lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotype. <span><span class="ref-journal">Am J Hum Genet. </span>2000;<span class="ref-vol">67</span>:1411–21.</span> [<a href="/pmc/articles/PMC1287918/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1287918</span></a>] [<a href="/pubmed/11055896" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11055896</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.berk.2010.664">Berk DR, Boente Mdel C, Montanari D, Toloza MG, Primc NB, Prado MI, Bayliss SJ, Pique LM, Schrijver I. Acanthosis nigricans and hypochondroplasia in a child with a K650Q mutation in FGFR3. <span><span class="ref-journal">Pediatr Dermatol. </span>2010;<span class="ref-vol">27</span>:664–6.</span> [<a href="/pubmed/21510009" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21510009</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.blomberg.2010.297">Blomberg M, Jeppesen EM, Skovby F, Benfeldt E. FGFR3 mutations and the skin: report of a patient with a FGFR3 gene mutation,acanthosis nigricans, hypochondroplasia and hyperinsulinemia and review of the literature. <span><span class="ref-journal">Dermatology. </span>2010;<span class="ref-vol">220</span>:297–305.</span> [<a href="/pubmed/20453470" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20453470</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.bober.2012.2336">Bober MB, Taylor M, Heinle R, Mackenzie W. Achondroplasia-hypochondroplasia complex and abnormal pulmonary anatomy. <span><span class="ref-journal">Am J Med Genet A. </span>2012;<span class="ref-vol">158A</span>:2336–41.</span> [<a href="/pubmed/22888019" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22888019</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.bonaventure.1996.33">Bonaventure J, Rousseau F, Legeai-Mallet L, Le Merrer M, Munnich A, Maroteaux P. Common mutations in the gene encoding fibroblast growth factor receptor 3 account for achondroplasia, hypochondroplasia and thanatophoric dysplasia. <span><span class="ref-journal">Acta Paediatr Suppl. </span>1996;<span class="ref-vol">417</span>:33–8.</span> [<a href="/pubmed/9055906" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9055906</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.bridges.1994.231">Bridges NA, Brook CG. Progress report: growth hormone in skeletal dysplasia. <span><span class="ref-journal">Horm Res. </span>1994;<span class="ref-vol">42</span>:231–4.</span> [<a href="/pubmed/7868078" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7868078</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.bridges.1991.56">Bridges NA, Hindmarsh PC, Brook CG. Growth of children with hypochondroplasia treated with growth hormone for up to three years. <span><span class="ref-journal">Horm Res. </span>1991;<span class="ref-vol">36</span> Suppl 1:56–60.</span> [<a href="/pubmed/1806487" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1806487</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.castrofeij_o.2008.243">Castro-Feij&#x000f3;o L, Loidi L, Vidal A, Parajes S, Ros&#x000f3;n E, Alvarez A, Cabanas P, Barreiro J, Alonso A, Dom&#x000ed;nguez F, Pombo M. Hypochondroplasia and Acanthosis nigricans: a new syndrome due to the p.Lys650Thr mutation in the fibroblast growth factor receptor 3 gene? <span><span class="ref-journal">Eur J Endocrinol. </span>2008;<span class="ref-vol">159</span>:243–9.</span> [<a href="/pubmed/18583390" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18583390</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.colvin.1996.390">Colvin JS, Bohne BA, Harding GW, McEwen DG, Ornitz DM. Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. <span><span class="ref-journal">Nat Genet. </span>1996;<span class="ref-vol">12</span>:390–7.</span> [<a href="/pubmed/8630492" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8630492</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.deng.1996.911">Deng C, Wynshaw-Boris A, Zhou F, Kuo A, Leder P. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. <span><span class="ref-journal">Cell. </span>1996;<span class="ref-vol">84</span>:911–21.</span> [<a href="/pubmed/8601314" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8601314</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.dorst.1969.260">Dorst JP. Hypochondroplasia. <span><span class="ref-journal">Birth Defects IV. </span>1969;<span class="ref-vol">5</span>:260–76.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.fano.2005.782">Fano V, Gravina LP, Pino MD, Chertkoff L, Barreiro C, Lejarraga H. High specificity of head circumference to recognize N540K mutation in hypochondroplasia. <span><span class="ref-journal">Ann Hum Biol. </span>2005;<span class="ref-vol">32</span>:782–8.</span> [<a href="/pubmed/16418051" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16418051</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.flynn.2003.193">Flynn MA, Pauli RM. Double heterozygosity in bone growth disorders: four new observations and review. <span><span class="ref-journal">Am J Med Genet A. </span>2003;<span class="ref-vol">121A</span>:193–208.</span> [<a href="/pubmed/12923858" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12923858</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.fofanova.1998.791">Fofanova OV, Takamura N, Kinoshita E, Meerson EM, Iljina VK, Nechvolodova OL, Evgrafov OV, Peterkova VA, Yamashita S. A missense mutation of C1659 in the fibroblast growth factor receptor 3 gene in Russian patients with hypochondroplasia. <span><span class="ref-journal">Endocr J. </span>1998;<span class="ref-vol">45</span>:791–5.</span> [<a href="/pubmed/10395236" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10395236</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.frydman.1974.223">Frydman M, Hertz M, Goodman RM. The genetic entity of hypochondroplasia. <span><span class="ref-journal">Clin Genet. </span>1974;<span class="ref-vol">5</span>:223–9.</span> [<a href="/pubmed/4838890" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 4838890</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.glasgow.1978.868">Glasgow JF, Nevin NC, Thomas PS. Hypochondroplasia. <span><span class="ref-journal">Arch Dis Child. </span>1978;<span class="ref-vol">53</span>:868–72.</span> [<a href="/pmc/articles/PMC1545272/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1545272</span></a>] [<a href="/pubmed/727810" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 727810</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.g_nthard.1995.35">G&#x000fc;nthard J, Fliegel C, Ohnacker H, Rutishauser M, Buhler E. Lung hypoplasia and severe pulmonary hypertension in an infant with double heterozygosity for spondyloepiphyseal dysplasia congenita and achondroplasia. <span><span class="ref-journal">Clin Genet. </span>1995;<span class="ref-vol">48</span>:35–40.</span> [<a href="/pubmed/7586642" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7586642</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.hall.1979.95">Hall BD, Spranger J. Hypochondroplasia: clinical and radiological aspects in 39 cases. <span><span class="ref-journal">Radiology. </span>1979;<span class="ref-vol">133</span>:95–100.</span> [<a href="/pubmed/472320" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 472320</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.heselson.1979.79">Heselson NG, Cremin BJ, Beighton P. The radiographic manifestations of hypochondroplasia. <span><span class="ref-journal">Clin Radiol. </span>1979;<span class="ref-vol">30</span>:79–85.</span> [<a href="/pubmed/421428" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 421428</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.heuertz.2006.1240">Heuertz S, Le Merrer M, Zabel B, Wright M, Legeai-Mallet L, Cormier-Daire V, Gibbs L, Bonaventure J. Novel FGFR3 mutations creating cysteine residues in the extracellular domain of the receptor cause achondroplasia or severe forms of hypochondroplasia. <span><span class="ref-journal">Eur J Hum Genet. </span>2006;<span class="ref-vol">14</span>:1240–7.</span> [<a href="/pubmed/16912704" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16912704</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.huggins.1999.396">Huggins MJ, Smith JR, Chun K, Ray PN, Shah JK, Whelan DT. Achondroplasia-hypochondroplasia complex in a newborn infant. <span><span class="ref-journal">Am J Med Genet. </span>1999;<span class="ref-vol">84</span>:396–400.</span> [<a href="/pubmed/10360392" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10360392</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.hulse.2012">Hulse T, Lin J-P, Irving M. Hypochondroplasia with hippocampal dysgenesis and neonatal onset of medial temporal lobe epilepsy. Poster. Leipzig, Germany: 51<sup>st</sup> Annual Meeting of the European Society for Paediatric Endocrinology. 2012.</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.johnson.1993.1">Johnson DE, Williams LT. Structural and functional diversity in the FGF receptor multigene family. <span><span class="ref-journal">Adv Cancer Res. </span>1993;<span class="ref-vol">60</span>:1–41.</span> [<a href="/pubmed/8417497" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8417497</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.jones.1990.404">Jones SM, Robinson LK, Sperrazza R. Prenatal diagnosis of skeletal dysplasia identified postnatally as hypochondroplasia. <span><span class="ref-journal">Am J Med Genet. </span>1990;<span class="ref-vol">36</span>:404–7.</span> [<a href="/pubmed/2202213" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2202213</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.kozlowski.1973.238">Kozlowski K. Hypochondroplasia. <span><span class="ref-journal">Progr Pediat Radiol. </span>1973;<span class="ref-vol">4</span>:238–49.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.kozlowski.1965.379">Kozlowski K, Bartkowiak K. Hypochondroplasia. <span><span class="ref-journal">Pediatr Pol. </span>1965;<span class="ref-vol">40</span>:379–90.</span> [<a href="/pubmed/14348699" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14348699</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.langer.1993.772">Langer LO Jr, Schaefer GB, Wadsworth DT. Patient with double heterozygosity for achondroplasia and pseudoachondroplasia, with comments on these conditions and the relationship between pseudoachondroplasia and multiple epiphyseal dysplasia, Fairbank type. <span><span class="ref-journal">Am J Med Genet. </span>1993;<span class="ref-vol">47</span>:772–81.</span> [<a href="/pubmed/8267011" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8267011</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.leroy.2007.3144">Leroy JG, Nuytinck L, Lambert J, Naeyaert JM, Mortier GR. Acanthosis nigricans in a child with mild osteochondrodysplasia and K650Q mutation in the FGFR3 gene. <span><span class="ref-journal">Am J Med Genet A. </span>2007;<span class="ref-vol">143A</span>:3144–9.</span> [<a href="/pubmed/18000903" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18000903</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.lie.2009.280">Lie CW, Chow W. Limb lengthening in short-stature patients using monolateral and circular external fixators. <span><span class="ref-journal">Hong Kong Med J. </span>2009;<span class="ref-vol">15</span>:280–4.</span> [<a href="/pubmed/19652235" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19652235</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.linnankivi.2012.3119">Linnankivi T, M&#x000e4;kitie O, Valanne L, Toiviainen-Salo S. Neuroimaging and neurological findings in patients with hypochondroplasia and FGFR3 N540K mutation. <span><span class="ref-journal">Am J Med Genet A. </span>2012;<span class="ref-vol">158A</span>:3119–25.</span> [<a href="/pubmed/23165795" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23165795</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.maroteaux.1988.105">Maroteaux P, Falzon P. <span><span class="ref-journal">Arch Fr Pediatr. </span>1988;<span class="ref-vol">45</span>:105–9.</span> [Hypochondroplasia. Review of 80 cases] [<a href="/pubmed/3389972" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3389972</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.matsui.1998.1052">Matsui Y, Yasui N, Kimura T, Tsumaki N, Kawabata H, Ochi T. Genotype phenotype correlation in achondroplasia and hypochondroplasia. <span><span class="ref-journal">J Bone Joint Surg Br. </span>1998;<span class="ref-vol">80</span>:1052–6.</span> [<a href="/pubmed/9853502" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9853502</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.mckusick.1973.11">McKusick VA, Kelly TE, Dorst JP. Observations suggesting allelism of the achondroplasia and hypochondroplasia genes. <span><span class="ref-journal">J Med Genet. </span>1973;<span class="ref-vol">10</span>:11–6.</span> [<a href="/pmc/articles/PMC1012968/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1012968</span></a>] [<a href="/pubmed/4697848" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 4697848</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.meyer.2003.177">Meyer MF, Menken KU, Zimny S, Hellmich B, Schatz H. Pitfall in diagnosing growth hormone deficiency in a hypochondroplastic patient with a delayed puberty. <span><span class="ref-journal">Exp Clin Endocrinol Diabetes. </span>2003;<span class="ref-vol">111</span>:177–81.</span> [<a href="/pubmed/12784193" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12784193</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.moloney.1996.48">Moloney DM, Slaney SF, Oldridge M, Wall SA, Sahlin P, Stenman G, Wilkie AO. Exclusive paternal origin of new mutations in Apert syndrome. <span><span class="ref-journal">Nat Genet. </span>1996;<span class="ref-vol">13</span>:48–53.</span> [see comments] [<a href="/pubmed/8673103" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8673103</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.mortier.2000.220">Mortier G, Nuytinck L, Craen M, Renard JP, Leroy JG, de Paepe A. Clinical and radiographic features of a family with hypochondroplasia owing to a novel Asn540Ser mutation in the fibroblast growth factor receptor 3 gene. <span><span class="ref-journal">J Med Genet. </span>2000;<span class="ref-vol">37</span>:220–4.</span> [<a href="/pmc/articles/PMC1734544/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1734544</span></a>] [<a href="/pubmed/10777366" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10777366</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.mullis.1991.265">Mullis PE, Patel MS, Brickell PM, Hindmarsh PC, Brook CG. Growth characteristics and response to growth hormone therapy in patients with hypochondroplasia: genetic linkage of the insulin-like growth factor I gene at chromosome 12q23 to the disease in a subgroup of these patients. <span><span class="ref-journal">Clin Endocrinol (Oxf). </span>1991;<span class="ref-vol">34</span>:265–74.</span> [<a href="/pubmed/1879059" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1879059</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.naski.1996.233">Naski MC, Wang Q, Xu J, Ornitz DM. Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia. <span><span class="ref-journal">Nat Genet. </span>1996;<span class="ref-vol">13</span>:233–7.</span> [<a href="/pubmed/8640234" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8640234</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.newman.1975.95">Newman DE, Dunbar JC. Hypochondroplasia. <span><span class="ref-journal">J Can Assoc Radiol. </span>1975;<span class="ref-vol">26</span>:95–103.</span> [<a href="/pubmed/1158967" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1158967</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.oberklaid.1979.140">Oberklaid F, Danks DM, Jensen F, Stace L, Rosshandler S. Achondroplasia and hypochondroplasia. Comments on frequency, mutation rate, and radiological features in skull and spine. <span><span class="ref-journal">J Med Genet. </span>1979;<span class="ref-vol">16</span>:140–6.</span> [<a href="/pmc/articles/PMC1012739/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1012739</span></a>] [<a href="/pubmed/458831" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 458831</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.pinto.2012.193">Pinto G, Cormier V, Le Merrer M, Samara-Boustani D, Fresneau L, Viaud M, Souberbielle JC, Pineau JC, Polak M. Efficacy and safety of growth hormone in the treatment of children with hypochondroplasia (HCH): Comparison with a historical cohort of untreated children with HCH. <span><span class="ref-journal">Hormone Res Paed. </span>2012;<span class="ref-vol">78</span>:193.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.prinos.1995.2097">Prinos P, Costa T, Sommer A, Kilpatrick MW, Tsipouras P. A common FGFR3 gene mutation in hypochondroplasia. <span><span class="ref-journal">Hum Mol Genet. </span>1995;<span class="ref-vol">4</span>:2097–101.</span> [<a href="/pubmed/8589686" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8589686</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.prinster.1998.109">Prinster C, Carrera P, Del Maschio M, Weber G, Maghnie M, Vigone MC, Mora S, Tonini G, Rigon F, Beluffi G, Severi F, Chiumello G, Ferrari M. Comparison of clinical-radiological and molecular findings in hypochondroplasia. <span><span class="ref-journal">Am J Med Genet. </span>1998;<span class="ref-vol">75</span>:109–12.</span> [<a href="/pubmed/9450868" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9450868</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.ramaswami.1998.99">Ramaswami U, Rumsby G, Hindmarsh PC, Brook CG. Genotype and phenotype in hypochondroplasia. <span><span class="ref-journal">J Pediatr. </span>1998;<span class="ref-vol">133</span>:99–102.</span> [<a href="/pubmed/9672519" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9672519</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.ravenna.1913.157">Ravenna F. Achondroplasie et chondrohypoplasie: contribution clinique. <span><span class="ref-journal">N Iconog Salpertriere. </span>1913;<span class="ref-vol">26</span>:157–84.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.ross.2003.61">Ross JL, Bellus G, Scott CI Jr, Abboudi J, Grigelioniene G, Zinn AR. Mesomelic and rhizomelic short stature: The phenotype of combined Leri-Weill dyschondrosteosis and achondroplasia or hypochondroplasia. <span><span class="ref-journal">Am J Med Genet. </span>2003;<span class="ref-vol">116A</span>:61–5.</span> [<a href="/pubmed/12476453" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12476453</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.rothenbuhler.2012.849">Rothenbuhler A, Linglart A, Piquard C, Bougn&#x000e8;res P. A pilot study of discontinuous, insulin-like growth factor 1-dosing growth hormone treatment in young children with FGFR3 N540K-mutated hypochondroplasia. <span><span class="ref-journal">J Pediatr. </span>2012;<span class="ref-vol">160</span>:849–53.</span> [<a href="/pubmed/22137367" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22137367</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.rousseau.1996.749">Rousseau F, Bonaventure J, Legeai-Mallet L, Schmidt H, Weissenbach J, Maroteaux P, Munnich A, Le Merrer M. Clinical and genetic heterogeneity of hypochondroplasia. <span><span class="ref-journal">J Med Genet. </span>1996;<span class="ref-vol">33</span>:749–52.</span> [<a href="/pmc/articles/PMC1050728/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1050728</span></a>] [<a href="/pubmed/8880574" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8880574</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.scott.1976.18">Scott CI Jr. Achondroplastic and hypochondroplastic dwarfism. <span><span class="ref-journal">Clin Orthop Relat Res. </span>1976;(114):18–30.</span> [<a href="/pubmed/1261109" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1261109</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.sommer.1987.949">Sommer A, Young-Wee T, Frye T. Achondroplasia-hypochondroplasia complex. <span><span class="ref-journal">Am J Med Genet. </span>1987;<span class="ref-vol">26</span>:949–57.</span> [<a href="/pubmed/3591840" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3591840</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.song.2012.2456">Song SH, Balce GC, Agashe MV, Lee H, Hong SJ, Park YE, Kim SG, Song HR. New proposed clinico-radiologic and molecular criteria in hypochondroplasia: FGFR 3 gene mutations are not the only cause of hypochondroplasia. <span><span class="ref-journal">Am J Med Genet A. </span>2012;<span class="ref-vol">158A</span>:2456–62.</span> [<a href="/pubmed/22903874" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22903874</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.specht.1975">Specht EE, Daentl DL. Hypochondroplasia. Clin Orthop Relat Res. 1975;110:249-55. [<a href="/pubmed/1098822" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1098822</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.tanaka.2003.69">Tanaka N, Katsumata N, Horikawa R, Tanaka T. The comparison of the effects of short-term growth hormone treatment in patients with achondroplasia and with hypochondroplasia. <span><span class="ref-journal">Endocr J. </span>2003;<span class="ref-vol">50</span>:69–75.</span> [<a href="/pubmed/12733711" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12733711</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.tavormina.1999.722">Tavormina PL, Bellus GA, Webster MK, Bamshad MJ, Fraley AE, McIntosh I, Szabo J, Jiang W, Jabs EW, Wilcox WR, Wasmuth JJ, Donoghue DJ, Thompson LM, Francomano CA. A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in the fibroblast growth factor receptor 3 gene. <span><span class="ref-journal">Am J Hum Genet. </span>1999;<span class="ref-vol">64</span>:722–31.</span> [<a href="/pmc/articles/PMC1377789/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1377789</span></a>] [<a href="/pubmed/10053006" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10053006</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.thauvinrobinet.2003.81">Thauvin-Robinet C, Faivre L, Lewin P, De Monl&#x000e9;on JV, Fran&#x000e7;ois C, Huet F, Couailler JF, Campos-Xavier AB, Bonaventure J, Le Merrer M. Hypochondroplasia and stature within normal limits: another family with an Asn540Ser mutation in the fibroblast growth factor receptor 3 gene. <span><span class="ref-journal">Am J Med Genet A. </span>2003;<span class="ref-vol">119A</span>:81–4.</span> [<a href="/pubmed/12707965" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12707965</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.thomeer.2002.292">Thomeer RT, van Dijk JM. Surgical treatment of lumbar stenosis in achondroplasia. <span><span class="ref-journal">J Neurosurg. </span>2002;<span class="ref-vol">96</span>:292–7.</span> [<a href="/pubmed/11990837" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11990837</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.thompson.1997.4169">Thompson LM, Raffioni S, Wasmuth JJ, Bradshaw RA. Chimeras of the native form or achondroplasia mutant (G375C) of human fibroblast growth factor receptor 3 induce ligand-dependent differentiation of PC12 cells. <span><span class="ref-journal">Mol Cell Biol. </span>1997;<span class="ref-vol">17</span>:4169–77.</span> [<a href="/pmc/articles/PMC232270/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC232270</span></a>] [<a href="/pubmed/9199352" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9199352</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.trotter.2005.771">Trotter TL, Hall JG., American Academy of Pediatrics Committee on Genetics.  Health supervision for children with achondroplasia. <span><span class="ref-journal">Pediatrics. </span>2005;<span class="ref-vol">116</span>:771–83.</span> [<a href="/pubmed/16140722" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16140722</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.walker.1971.95">Walker BA, Murdoch JL, McKusick VA, Langer LO, Beals RK. Hypochondroplasia. <span><span class="ref-journal">Am J Dis Child. </span>1971;<span class="ref-vol">122</span>:95–104.</span> [<a href="/pubmed/5564166" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 5564166</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.webster.1996.4081">Webster MK, D'Avis PY, Robertson SC, Donoghue DJ. Profound ligand-independent kinase activation of fibroblast growth factor receptor 3 by the activation loop mutation responsible for a lethal skeletal dysplasia, thanatophoric dysplasia type II. <span><span class="ref-journal">Mol Cell Biol. </span>1996;<span class="ref-vol">16</span>:4081–7.</span> [<a href="/pmc/articles/PMC231404/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC231404</span></a>] [<a href="/pubmed/8754806" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8754806</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.webster.1996.520">Webster MK, Donoghue DJ. Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia. <span><span class="ref-journal">EMBO J. </span>1996;<span class="ref-vol">15</span>:520–7.</span> [<a href="/pmc/articles/PMC449970/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC449970</span></a>] [<a href="/pubmed/8599935" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8599935</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.wilkin.1998.711">Wilkin DJ, Szabo JK, Cameron R, Henderson S, Bellus GA, Mack ML, Kaitila I, Loughlin J, Munnich A, Sykes B, Bonaventure J, Francomano CA. Mutations in fibroblast growth-factor receptor 3 in sporadic cases of achondroplasia occur exclusively on the paternally derived chromosome. <span><span class="ref-journal">Am J Hum Genet. </span>1998;<span class="ref-vol">63</span>:711–6.</span> [<a href="/pmc/articles/PMC1377389/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1377389</span></a>] [<a href="/pubmed/9718331" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9718331</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.wynnedavies.1991.644">Wynne-Davies R, Patton MA. The frequency of mental retardation in hypochondroplasia. <span><span class="ref-journal">J Med Genet. </span>1991;<span class="ref-vol">28</span>:644.</span> [<a href="/pmc/articles/PMC1015801/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1015801</span></a>] [<a href="/pubmed/1956068" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1956068</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.wynnedavies.1981.508">Wynne-Davies R, Walsh WK, Gormley J. Achondroplasia and hypochondroplasia. Clinical variation and spinal stenosis. <span><span class="ref-journal">J Bone Joint Surg Br. </span>1981;<span class="ref-vol">63B</span>:508–15.</span> [<a href="/pubmed/7298674" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7298674</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.yasui.1997.298">Yasui N, Kawabata H, Kojimoto H, Ohno H, Matsuda S, Araki N, Shimomura Y, Ochi T. Lengthening of the lower limbs in patients with achondroplasia and hypochondroplasia. <span><span class="ref-journal">Clin Orthop Relat Res. </span>1997;(344):298–306.</span> [<a href="/pubmed/9372781" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9372781</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hypochondroplasia.REF.young.1992.831">Young ID, Ruggins NR, Somers JM, Zuccollo JM, Rutter N. Lethal skeletal dysplasia owing to double heterozygosity for achondroplasia and spondyloepiphyseal dysplasia congenita. <span><span class="ref-journal">J Med Genet. </span>1992;<span class="ref-vol">29</span>:831–3.</span> [<a href="/pmc/articles/PMC1016183/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1016183</span></a>] [<a href="/pubmed/1453438" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1453438</span></a>]</div></li></ul></div></div><div id="hypochondroplasia.Chapter_Notes"><h2 id="_hypochondroplasia_Chapter_Notes_">Chapter Notes</h2><div id="hypochondroplasia.Author_History"><h3>Author History</h3><p>Arthur S Aylsworth, MD, FACMG; University of North Carolina (1999-2005) <br />Gary A Bellus, MD, PhD (1999-2005; 2013-present) <br />Michael B Bober, MD, PhD (2013-present)<br />Clair A Francomano, MD; National Institutes of Health (2005-2013) <br />Thaddeus E Kelly, MD, PhD; University of Virginia Hospital (1999-2005) <br />Sarah M Nikkel, MD (2013-present)<br />George E Tiller, MD, PhD (2013-present)</p></div><div id="hypochondroplasia.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>26 September 2013 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>12 December 2005 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>13 February 2003 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>15 July 1999 (pb) Review posted live</div></li><li class="half_rhythm"><div>27 April 1999 (gb) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1477</span><span class="label">PMID: <a href="/pubmed/20301650" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301650</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/hyper-card/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/x-hed/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1477&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1477/?report=reader">PubReader</a></li><li><a href="/books/NBK1477/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1477" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1477" style="display:none" title="Cite this Page"><div class="bk_tt">Bober MB, Bellus GA, Nikkel SM, et al. Hypochondroplasia. 1999 Jul 15 [Updated 2013 Sep 26]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1477/pdf/Bookshelf_NBK1477.pdf">PDF version of this page</a> (490K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#hypochondroplasia.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#hypochondroplasia.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#hypochondroplasia.Clinical_Characteristi" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#hypochondroplasia.Genetically_Related_Al" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#hypochondroplasia.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#hypochondroplasia.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#hypochondroplasia.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#hypochondroplasia.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#hypochondroplasia.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#hypochondroplasia.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#hypochondroplasia.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=2261[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">FGFR3</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK1477+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1492602" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1492602" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1492602" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1492602" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301331" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Achondroplasia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Achondroplasia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Pauli RM, Legare JM. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24830047" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">TRPV4</i>-Associated Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">TRPV4</i>-Associated Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Schindler A, Sumner C, Hoover-Fong JE. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301341" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Mucopolysaccharidosis Type I</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Mucopolysaccharidosis Type I<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Clarke LA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31633898" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Schmid Metaphyseal Chondrodysplasia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Schmid Metaphyseal Chondrodysplasia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Richmond CM, Savarirayan R. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301303" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Noonan Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Noonan Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Allanson JE, Roberts AE. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301650" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301650" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e04149f75f66d18aa1d82ba">Hypochondroplasia - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Hypochondroplasia - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:02:07-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal102&amp;ncbi_phid=CE89ABD2E04034F1000000000844037F&amp;ncbi_session=CE89ABD2E04149F1_2116SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1477%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1477&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1477/&amp;ncbi_pagename=Hypochondroplasia - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE89ABD2E04149F1_2116SID /projects/books/PBooks@5.22 portal102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>